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PREFACE 
 
Presentation plan:  
This thesis is being submitted as part of Master of Philosophy degree in International 
Community Health at the University of Oslo. The current submission follows option 2 among 
the forms of thesis accepted as highlighted in the circular Requirements of the MPhil Thesis, 
February 2011 from the Department of Community Medicine. Hence, results and discussion 
of findings is not included. 
As presented in the materials section, voluminous data were collected. The thesis is started 
with an abstract of the first paper submitted for publication. This follows the literature review 
section in which a relevant description of the study theme, focused but not limited to the 
variables, used in the first paper is presented.   
Brief methodological consideration is presented together with detailed methods and materials 
in the Methodology section. List of cited references, pertinent appendices and a copy of the 
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Introduction Nepal is an ambivalent society in terms of alcohol use: alcohol consumption is 
frowned upon among traditionally ruling upper caste people whereas its use is socially 
accepted among certain lower caste people. We hypothesized that presence of social taboo 
leads to higher rates of depression among consumers of alcohol and that the explanations of 
comorbid depression across the two strata could be different. Aims  1) To investigate if 
belonging to the tabooed social stratum led to higher rates of concomitant major depression. 
2) To correlate sociodemographic and clinical factors with the presence of major depression 
in the two social strata. Methods A cross-sectional survey was carried out among 
consecutively admitted 188 Alcohol-use disorder (AUD) patients in multiple residential 
alcohol treatment units in Kathmandu during the period July- December, 2010. We recorded 
socio-demographic data and administered the alcohol use and depression modules of WHO 
Composite International Diagnostic Interview (CIDI) 2.1, and the Alcohol-use disorder 
Identification Test (AUDIT). Results Depressed AUD patients compared to non-depressed 
AUD patients had significantly more severe alcohol problems and were less likely to be 
cohabitating with a partner. Lifetime and 12-month prevalence of major depressive episodes 
among the alcohol abuser/dependent patients were found to be 45% and 36% respectively, 
with marginally higher rates of major depression in the non-tabooed group. Lacking a stable 
employment, having experienced alcohol-induced blackout, and longer abstention were 
positively associated with major depression in the non-tabooed group. In case of the tabooed 
group, parental problem drinking appeared to be the single most important independent 
correlate (OR=7.7, 95% CI= 2.6-22.3) of comorbid MD. Conclusions Major depression is 
common among patients with alcohol-use disorders in Nepal. Among treatment seekers, 
social taboo on alcohol use seems to have insignificant effect on rates of comorbidity. 
However, lack of stable source of income and alcohol problem severity in case of the non-
tabooed class and familial predisposition in case of the tabooed class may indicate potential 
risk factors for depressive comorbidity. 
Keywords:  Nepal, alcohol, depression, comorbidity, taboo.  
Correspondence to:  Sudan Prasad Neupane, thelonelyplanet@gmail.com 
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CHAPTER 1.  INTRODUCTION                                                             
1.1 Background 
 
The distribution of psychiatric illnesses including those related to alcohol use is universal and 
the burden is heavy. A mixed occurrence of two or more of these illnesses heralds challenges 
to reaching early diagnosis and institution of appropriate treatment- even among those who 
seek help. Failure to curb the problems rigorously and early in course of the disease increases 
risks of adverse outcomes in terms of physical, mental and social wellbeing as so happens in 
familial and professional fronts. Today, almost three quarters of the global burden of 
neuropsychiatric disorders occur in low- and middle-income countries (2;3). The dimensions 
of disease epidemiology may vary by regions. This is especially true in case of psychiatric 
morbidities where socio-cultural attribution may modulate relationships between the 
disorders. 
 
Psychiatric comorbidity is a co-occurrence of more than one psychiatric diagnosis in the 
same individual at the same time, sometimes owing to diagnostic misclassification of 
underlying single pathology. Alcohol abuse and alcohol dependence, together called alcohol-
use disorders (AUD), are often associated with comorbid conditions, nicotine dependence 
being the most common (4). This is followed by mood and anxiety disorders which are also 
quite often comorbid with alcohol-use disorders (5). Major depression is a cluster of 
symptoms of low mood and anhedonia as defined by American Psychiatric Association (see 
appendix). The co-occurrence of major depression in alcohol-use disorders is rather a rule 
than just chance (6;7). 
 
Nepal is a low income secular republic lying between India and China  and covers an area of 
147,181 sq. km (8;9). The majority (80%) of its 29.3 million inhabitants  follow Hinduism 
(9), a religion cum-culture, with its multifaceted construct of caste system. The caste 
determines an individual's behavior, obligations and expectations in the society (10), also 
those relating to the use of alcoholic beverages. The caste division, based on Hindu culture, 
and classified according to the profession, was formally authenticated by an archaic civil 
code Muluki Ain in 1854. The code also categorized the whole Nepalese society into two 
distinct groups according to the acceptability of alcohol consumption. One end of the caste 
system is the historically ruling upper class constituted by Brahmins (the priests and the 
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teachers) and Kshatriyas (the warriors and the rulers) who are considered „purer‟ being twice 
born, wear holy thread on their body and among whom alcohol use is frowned upon. These 
people together constitute the Tagadhari community. On the other hand, the so called lower 
castes which include (traders, farmers, artisans, and labourers), identified by surnames Rai, 
Limbu, Gurung, Magar, Tamang, Newars, etc. constitute the Matwalis. Matwali literally 
means an alcohol user. Alcohol enjoys social and religious sanction among people belonging 
to this group. Although much of this observance has probably diminished (11), studies 
indicate that association of alcohol with taboo in certain caste and ethnicity is even valid 
today. For example, one study identified that the abstinence rates was 85% among the 
Tagadharis and 40% among the Matwalis (12). Thus Nepal is clearly an ambivalent society in 
regard to use of alcohol. 
 
„„A resource limited district hospital in Eastern hills of Nepal. In front of the outpatient clinic 
is a local bar, a glass of rice brewed (approx 20% ethanol) Rakshi costs 10 US cents 
equivalent Rupees. A laborer woman of middle ranked caste in her 40s is a regular customer. 
She is also the hospital client once in around 3 months-alcohol induced hepatitis/grade two 
hepatic encepahlopathy with known depressive disorder. Hospital admission deferred because 
of inability to pay. The husband (working as a security guard in Dubai) visits the clinician 
and asks if the sick liver could be replaced- the answer was yes, in UK. The woman dies in 
two months. The husband self-medicates the bereavement with Rakshi; meets the clinician in 
the town and shares his trouble- but denies psychiatric problems/treatment. Six months later 
the son is rushed to the hospital: diagnosis- acute stress reaction (the cause: the father had 
committed suicide). One day, the clinician finds the son injecting illicit drugs in a nearby 
temple; obviously drinks too.‟‟ This vignette of vicious cycle may be representative of many 
untold stories of today‟s Nepal. The same makes the conceptual framework of this research 
work. 
 
Home brewing and consumption of alcoholic beverages is common in most regions of the 
country. Despite strong social stigma associated against alcoholism, a growing wary of its 
increased use exists. Liquor production at home is one of the common employment ventures 
undertaken by women and the current liquor control act of Nepal allows the production of 
home-made forms of alcohol for domestic use (8). Home brewing is common in the rural 
settings, but also occurs in urban areas. A blending of oriental drinking culture survived by 
the practice of home brewing, and consumption of industrially brewed alcoholic drinks co-
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exists in Nepal. There are no nationally representative population level data on the prevalence 
of alcohol-use disorders and other psychiatric diseases in Nepal. By and large, the scale of 
these problems is unknown. As a tip of an iceberg, a community survey in Eastern Nepal 
showed that as many as one in four adults living in Nepalese towns may be dependent to 
alcohol (13). Alcohol is thus considered a common commodity, but its morbidity may be an 
unscaled hillock of this mountainous country. 
 
A complex socio-cultural dimension and poor health economics together make Nepal a 
unique ground for alcohol and related psychiatric morbidities. There is only one „mental 
hospital‟ with a total of 0.20 beds per 100,000 populations (14). According to the same World 
Health Organization (WHO) report, a majority of these users are treated in outpatient 
facilities, mostly by non specialists. The total number of human resources working in mental 
health facilities or private practice per 100,000 population is 0.59 of which 0.13 are 
psychiatrists, 0.06 other medical doctors, 0.27 nurses, 0.02 psychologists, and 0.10 other 
health or mental health workers (14). These figures are comparable with the statistics from 
India (15) but in short of huge necessity as compared to the developed nations. For example, 
in Norway roughly 120 beds and 20 psychiatrists are available for every 100,000 population 
(16). The government of Nepal spends 0.08% of the total health budget on mental health 
while the family of the mentally ill has to spend out of pocket around 25,000 Nepalese 
Rupees (approximately USD 350) per year as direct services costs (14). 
 
Given the resource constraints and stigma associated not only with alcoholism but also with 
other mental illnesses, it can be assumed that those patients who attend hospital represent a 
fraction of a much neglected problem. Excessive consumption of alcoholic drinks, being 
afflicted with mood disturbances, and having suicidal ideation are common vignettes of 
psychiatric presentations. Of particular concern in Nepal is an alarmingly high proportion of 
younger population whose drinking career starts even before adolescence (12). Few hospitals 
run detoxification services to substance dependent individuals and an increasing number of 
12-step based rehabilitation centres are operating in urban areas. Too little is known about the 
patient characteristics and affective comorbidity among treatment receivers at these centres. 
Enduring social taboo on alcohol use germane to most oriental societies may have bearing in 
the depressive psychopathology. Conversely, such taboo may alter the threshold of self 
medicating behavior. There is a need to sensitize health professionals and draw 
administrative attention to raise efforts in effective identification and appropriate treatment of 
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those individuals. Moreover, there is an urgent need to carry out epidemiological studies to 
scale the seriousness of the problem. Biomedical researches with a potential of bridging gap 
of information from and between the rich and the poor nations are equally important to 
understanding the dimensions of epidemiology of psychiatric illnesses. Treatment units may 
provide important venues and insights to understanding the epidemiology of alcohol-use 




1.2  LITERATURE REVIEW  
1.2.1  Burden of Alcohol-use disorders is heavy 
Alcohol is probably the only legal and the commonest substance of abuse after nicotine in 
most regions of the world. Alcohol use started with prehistoric ages and has taken place 
throughout the past millennia; however, health outcomes of its use became a subject of 
concern only since last few decades. World Health Organization (WHO) estimates that there 
are about 2 billion people worldwide who consume alcoholic beverages and 76.3 million 
have a diagnosable alcohol-use disorder (16). The same report estimates 1.8 million annual 
deaths (3.2% of total) and 58.3 million (4% of total) of disability adjusted life years (DALYs) 
attributed to alcohol globally. Alcohol constitutes the largest risk factor for DALYs lost in 
middle income countries and the third largest in all income group countries (17). 
 
Against the global average of 5.1 L, France, Ireland, Uganda, Luxemburg and Czech 
Republic (>13 L) top the list of adult per capita consumption of alcohol (2;16). WHO reports 
recent and steady increase in its consumption in the South East Asian region. The 
consumption of recorded alcohol in most Muslim populations and in South Asian countries 
seems to be lower than in Europe and Americas. However, unrecorded alcohol consumption 
is estimated to be at least two thirds of all alcohol consumption in the Indian subcontinent, 
about half of consumption in Africa, and about one third in Eastern Europe and Latin 
America (18). While drinking cultures keep the tradition alive, poverty and the majority of 
production via home brewing give vigor and social sanction to some groups provide a unique 
dimension to its use in Nepal. While the use of alcohol seems to be higher among the lower 
social strata people in the developed countries, its use may be a matter of exuberance among 
the higher strata in low income countries. However, the distribution of alcohol-use disorders 
is arguably rather universal.   
 
The 12 months prevalence of alcohol dependence in US general population reported by a 
large survey (N=43,093) assessed by using DSM criteria was 8.5% (19). A community 
survey (n=2344) conducted in an Eastern town of Nepal using the CAGE questionnaire 
showed prevalence of alcohol dependence among 19.3% of the randomly selected general 
population (13). The latter study highlights middle aged illiterate males of lower caste as the 
most vulnerable group for alcohol dependence. A communication from WHO's World Health 
Survey (n= 8663) implicate Nepalese male youths to indulge in significantly higher (1.3%) 
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events of episodic drinking as compared to their female (0.3%) counterparts (20). The same 
survey, on the other hand, notes that females indulge in heavy and hazardous drinking more 
often (4%) than do males (3%). As high as 75% females and 53% males were life time 
abstainers in Nepal (21). But rates  of past 12-month abstinence may be up to 45% higher 
(85% vs. 40%) among people who belong to the socially sanctioned group as compared to the 
group that has taboo on the consumption of alcohol (12). 
 
A survey done among children and youths aged between 10 and 17 years (n = 426) in 16 
districts of Nepal found that 17.4% of the respondents had consumed alcohol at least once in 
the preceding 12 month period (12). The prevalence among boys (21.8%) was almost double 
that of girls (11.2%) indicating gender variation in alcohol using population. The study also 
found that the rate of reported drinking in the past 30 days was 10.1% (boys) and 7.9% 
(girls). One half of those Nepalese children who were drinking initiated alcohol before the 
age of 13 (12). Unfortunately, nationally representative population level prevalence rates of 
alcohol consumption and related disorders are not available. Available data, however, 
illustrate that the problems related to alcohol is already an emergent public health issue in 
Nepal (12;13;22). 
 
Studies have revealed that alcohol consumption is associated with more than 60 types of 
disease and injury (23). There is also evidence that about 20% patients seen in clinical 
practice may present underlying alcohol misuse, at least in the western settings (24;25); in 
Nepal as many as 16.5% physically ill persons referred to psychiatric consultation had an 
alcohol-use disorder (26). The contribution of patients attending hospital for treatment in 
Nepal, however, does not directly reflect such huge burden of alcohol related disorders. The 
extent of treatment seeking for one‟s alcohol related problems is unknown in the context of 
Nepal, but even in American NESARC study of general population, only 6% AUD patients 
sought treatment in the year preceding assessment (19). Even less is known as to who among 
them actually seek help. Among the indirect evidences of the burden of alcohol-use disorders 
may be the increasingly large number of alcohol and drug rehabilitation centres being 
operated in urban concentrations of the country. 
1.2.2 Depression and anxiety disorders are common 
WHO‟s 2005 report attributed 31∙7% of all years lived-with-disability to neuropsychiatric 
conditions: the leading disorder that contributed to this total was Unipolar major depression 
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(11∙8%) followed by alcohol-use disorders (3∙3%) (27). In the American general population, 
the lifetime prevalence of generalized anxiety disorder (GAD) is 5.1%, with a 12-month 
prevalence measured at 3.1% with female preponderance (28), the median age of onset 
occurring during the early 20s (29). Depression is the leading cause of disability in the United 
States for individuals aged between 15 and 44 (16). Results from the American National 
Epidemiologic Survey on Alcoholism and Related conditions (NESARC) showed that the 
prevalence of 12-month and lifetime DSM-IV major depressive disorder was 5.3% and 
13.2%, respectively. People from minority background (which includes Asians) are suggested 
to have a lower risk for MDD (30). 
 
In the South African Stress and Health Study (n=4351), the 12-month prevalence of any 
DSM-IV disorder was found to be 16.5%, with 26.2% of respondents with disorder classified 
as severe cases and an additional 31.1% as moderately severe cases. The most common 
disorders were agoraphobia (4.8 %), major depressive disorder (4.9%) and alcohol abuse or 
dependence (4.5%) (31). Similar study from Israel showed 17%of the adult population had a 
lifetime occurrence of a mood or anxiety disorder, while nearly one in 10 (9.7%) reported a 
mood or anxiety disorder occurring during the previous 12 months (32). Mood disorders were 
twice as common as anxiety disorders (32). 
 
Various studies from Nepal indicate higher rates of anxiety and depressive symptoms among 
vulnerable group of people. A cross-sectional survey conducted among 290 internally 
displaced persons in Nepal in 2003 showed alarmingly high rates of anxiety and depression 
symptomatology (80.7 and 80.3% respectively) while 53.4% had PTSD symptomatology 
(33). Approximately one in five tortured and nontortured Bhutanese refugees living in Nepal 
were found to be living with psychiatric disability (34). The prevalence in general population 
of an area in West Nepal was anxiety: 28%, depression: 30%, and a self reported distress of 
the so called Jhum-Jhum: 42% (35).  Scale measures of anxiety and depression using Beck 
inventories classified a third of Nepalese adults in a hilly district as being depressed and a 
quarter being anxious (22). This raises a question of validity of measures of mental health 
across cultures. It is unfortunate that the tools for assessment of mental health standardized 
according to the ethnic dimensions and local context are hard to produce and available tools 
are less valid. Among psychiatric comorbidity in patients referred to psychiatrist from other 
disciplines, dissociative/conversion disorders were the commonest (17.2%) followed by 
alcohol use-related disorders (16.5%) and depressive disorder (13.2%) (26). There is a need 
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to characterize the burden of these psychiatric comorbidities in Nepalese clinics and a 
detailed investigation on their epidemiology is pending. 
1.2.3  Association between alcohol-use disorder and depression/anxiety  
Physical complaints are commonly encountered among alcohol consumers, both in 
community and clinical samples (36).  Many other studies delineate alcohol-use disorders 
with other mental illnesses.  Mood disturbances are arguably the most common psychiatric 
complaint among treatment seeking patients with an alcohol-use disorder, affecting over 80 
percent of alcoholic abuser/dependent population at some point in their drinking careers 
(37;38). According to a review of epidemiological surveys, field studies and family studies, 
between 8.3% and 56.2% of inpatient alcoholics, with a median prevalence of 22.9% met the 
criteria for GAD (39). Joshua & Sarah (2010) came up with 46.2% of comorbidity between 
the two conditions strongly supporting the previous finding. The American National 
Epidemiologic Survey on Alcohol and Related Conditions further confirmed a positive and 
significant (P<.05) association between most substance use disorders and independent mood 
and anxiety disorders (19).  
 
Consistently high rates of comorbidity have been found between alcohol-use disorders and a 
number of mood and anxiety disorders in both national epidemiological surveys (6;19;28;40) 
and clinical studies (41-43). The comorbidity seems to be more often met with alcohol 
dependence than alcohol abuse (44). While numerous studies (40;45) implicate major 
depression as a secondary pathology, many other studies (46;47), however, attribute alcohol 
abuse as a secondary illness – as a result of self medication for depressed mood. Independent 
substance abuse and mood disorders or anxiety states may also be common (48).  
 
In a tertiary care hospital in Nepal approximately 83% of Psychiatric emergencies received 
the diagnosis of Category F of the ICD-10. Mental and behavioral disorder due to substance 
use (F10-19) was the most common disorder (30%), followed by mood/affective disorders 
(23%) and neurotic, stress-related anxiety disorders (16%) (49). Uncertainties exist about the 
prevalence and co-morbidity of alcohol-use disorders and independent mood and anxiety 





Alcohol-use disorders and major depression may be linked through several possible 
mechanisms: a) both are separate entities but are diagnostic orphans b) one disorder leads to 
another, and c) a common etiology exists leading to both the disorders.   
Although many research works have tried to delineate the causal links between alcohol 
dependence and mood and anxiety disorders, little is consensual regarding the „primariness‟of 
either disorder. A recent review, and based mainly on the author‟s earlier analysis propose 
that causal links exist between the two disorders, with alcohol-use disorders being the more 
plausible primary phenomenon (51;52). This observation was supported by a Danish register-
based study which, without rejecting the reverse temporal order, concluded that AUDs are 
usually the index pathologies (53). Despite the frequent comorbidity, no single definitive 
causal or common etiological predictors have been identified that underlies both the disorders 
(30). AUDs may be even more frequently comorbid with nicotine and other substance use 
disorders (54). Structural equation modeling used in such analyses, are however, far from 
comprehensible raising methodological issues.  
 
An observational study conducted in a tertiary level hospital in Nepal showed that 50 out of 
53 patients admitted with an ICD-10 diagnosis of mental and behavioral disorder due to the 
use of alcohol were suffering from depressive episode (55). This universality of the co-
occurrence may be an exaggeration of symptom overlap; but it can be a reflection that severe 
mood disturbance may be a force driving help seeking behaviour. 
 
1.2.4  Correlates of AUD-MD comorbidity 
An analysis of acamprosate trial studies from 10 European countries showed that profiles of 
depressed patients among those with an alcohol-use disorder may be distinct from those who 
are not depressed (56). It identified five predictors of depressed patients as being female, 
younger, unemployed, living alone, and episodic drinker. However, it was not identified 
whether unemployment and divorce led to MD or Vice versa because the direction of these 
characteristics may go both ways. A large clinical inpatient dataset from Australia, however, 
suggested that male patients with mental disorder were more likely to have an AUD, but 
psychiatric comorbidity in general was more common among males (12% vs 7%); with 
younger age (20-49 years) than gender being more important predictor of comorbidity (57). A 
meta-analysis of studies from at least 64 clinical venues showed that age was a moderator of 
AUD- MD comorbidity where the association was stronger in older samples (30). Most of the 
studies in the meta-analysis indicated that early onset of habitual drinking was a predictor of 
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MD. The association with concurrent use of alcohol and other substance was also found to be 
consistent among the comorbid patients (30).  
 
In gist, older age (30), early onset of alcohol abuse (58;59), white race (30;60), and low 
socioeconomic status (61) are often implicated as risk factors for major depression among 
patients with AUDs. Another notion attributes depressive comorbidity to the pattern of 
alcohol consumption and severity of problems caused by harmful drinking. Following 
Cloninger‟s proposed typologies of alcoholism (62), a number of studies have investigated 
the children of problem drinkers suggesting that parental problem drinking relates both to 
AUDs and depressive mood in the off-springs (63-65). The applicability of these findings 
needs to be corroborated in more regional settings. AUD patients belonging to racial/ethnic 
minority origin have been found to generally report lower levels of depression than do their 
Caucasian counterparts in Western settings (30). The argument that minority groups, 
probably with immigrant background are less likely to have unstable mood is contestable, and 
less convincing. Most of the literature by virtue of their research settings list Asian 
population as a minority group, or often as „others‟ thus leading to no inferable details about 
them. 
 
Earlier study from Nepal also showed a preponderance of co-occurring major depression 
among married males and educated clients from the towns over unmarried, females, and 
illiterate rural dwellers. People from the so-called upper castes had higher proportions of co-
occurring depression disorders (55). This under-sampled clinical study was contested by 
Kohrt and colleagues (2009) by their multiple ethnographic and epidemiological approaches 
where they found lower socioeconomic status of people in the lower social strata (also on the 
basis of caste system) compared to dominant upper castes were much more (about double) 
prone to have depression and anxiety disorder (22). Yet another study of treatment seeking 
problem drinkers showed that about 42% of the alcohol dependent clients had concurrent 
major depression, which after detoxification fell to about 17% (66). A comprehensive 
understanding of the correlates of the co-occurrence of these two disorders is pending. 
 
We have sufficient evidence to propose that caste based disparities in mental health in the 
context of Nepal is not just an artifact. Differential occurrences of comorbidity in the 
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background of socio-cultural tolerability of alcohol in an ambivalent oriental society are, 
however virgin lands of psychiatric research. 
 
1.2.5 Comorbidity complicates either disorder and increases risk of self harm 
It is can be argued that regardless of whichever disorder comes earlier in the sequential 
ordering of the comorbidity, the importance lies with identifying the predictors of the dual 
diagnosis and identification of effective interventions.  
 
A prospective study from Iceland demonstrated that patients with no comorbid diagnoses had 
the fewest lifetime admissions; whereas agoraphobia/panic disorder predicted frequent 
readmission (odds ratio 5.8) (67). There is ongoing debate regarding the initiation of 
antidepressants among depressed patients with comorbid alcohol-use disorder (68). Co-
occurring depression among AUD patients not only impairs neuropsychological functioning 
(69) but also predicts relapse to alcohol use (70) and increased risk for suicidal behaviour 
(71). Clearly, the clinical management of comorbid illness is complex and outcome less 
favorable. Integrated psychosocial, cognitive behavior therapy and pharmacotherapy form the 
basis of treatment among these individuals in developed setups. Quite ironically in populous 
third world countries, there are sufferers, and there are caregivers: but who are suffering, 
what they are suffering from, who treat them and how they are treated have so far remained 
meager issues.  
 
There is no organized treatment in Nepal for what in the west is called a dual diagnosis. 
Baseline data on the same are needed to draw attention from clinical practitioners and 
policymakers. 
 
Unintentional injuries alone account for about one third of the 1.8 million deaths attributed to 
alcohol annually, likewise neuropsychiatric conditions account for close to 40% of the 58.3 
million DALYs (27). In general, affective disorders and substance use disorders are the most 
common diagnoses in suicides (72). Retrospective analyses have found between 25 % and 
64% (73;74) of individuals committing suicide suffered from mood disorders; the 
contribution of bipolar disorders was just under 5% (72). Cheng and colleagues (1995) 
reported from Taiwan an overwhelming association (87%) between individuals committing 




According to a cohort study of 4022 depressed Canadian patients, the standardized mortality 
ratio for suicide as a cause of death was 26-fold (76) and in a study of 40,000 Norwegian 
military conscripts who abusing alcohol were 6.9 times as likely to commit suicide as those 
who were not (77). Of the 1863 patients with a history of alcohol dependence or abuse and 
depressive symptoms included in a recent WHO/ International Society for Biomedical 
research on Alcoholism (ISBRA) study, over 15% had history of both the conditions; the 
subgroup analysis on comorbid AUD and depressive disorder showed strong correlation with 
suicidal ideation (78). 
 
Depression, alcohol abuse and suicidality (suicidal ideation, plan and attempts) remain the 
great challenges of present global public health. The comorbidity of problem drinking, 
depression and suicidality among adolescents have been found to be very high (79). In a 
study from Singapore, 27% of completed suicides were attributable to depression but 
prevalence of substance abuse and comorbidity was found to be lower in Singaporean suicide 
subjects, which was a notable difference from other studies done in the Western countries 
(80). This probably reflects the regional differences in terms of comorbidity. 
  
Suicide is the leading (16% of all) cause of death among women of reproductive age group in 
Nepal (81). Data are lacking regarding the pathway of suicidal ideation, substance use, 
familial predisposition, among other risk factors, to completed suicides. This makes suicide 
an integral component of the current study. 
1.2.6  Classification system and assessment tools may explain some of the variations in 
psychiatric research findings. 
Unlike most other medical conditions, diagnosis of many psychiatric disorders is not straight 
forward. Often the socio-cultural values, norms and clinician‟s judgment influence the 
diagnosis. Many symptoms of alcohol withdrawal and intoxication may overlap with those of 
mood and anxiety disorders thus complicating the diagnosis being made. Hence, a paucity of 
techniques that measure appropriately the index disorders and help to differentiate acute 
alcohol use related symptoms from axis I psychiatric disorders present a diagnostic challenge 
(19). Besides, classification system should be improved to facilitate quality improvement of 
mental health systems (82). Diagnostic misclassification weakens the brevity of psychiatric 
clinical practice and demands more research. However, the usefulness of even „gold-





Furthermore, studies conducted on the same theme may employ differing measures of 
disorders. A typical example is depression, which is elucidated in terms of major depression 
disorders, depressive episodes, depressive symptoms, psychological distress, among other 
measures. This hinders a generalisable understanding of the common phenomenon, making 
interpretations difficult. Many of the differences observed in studies discussed above may 
owe to the measures used. The social construct of mental disorders make the effort of 
uniformity of diagnosis even more challenging (84;85). Methodological issues pertaining to 
such research has been discussed in the section methodological consideration. 
 
1.2.7 Objective measures of alcohol use and role of AUD in immune-modulation  
Several biochemical and hematological parameters, such as gamma-glutamyltransferase 
(GGT) activity, aspartate aminotransferase (AST) activity, high density lipoprotein 
cholesterol (HDL-C) content of serum, and erythrocyte mean corpuscular volume (MCV) are 
established markers of alcohol intake (86). These investigations provide important prognostic 
information and can be used to monitor abstinence (86); at the same time these may provide 
complementary evidences for psychometric tests such as TLFB and AUDIT (87). These 
markers may be useful in substantiating the findings of structured questionnaire such as 
alcohol module of CIDI and AUDIT, and TLFB used in our study. The combination of those 
tests may give more accurate reflection of recent to several weeks of alcohol intake, and help 
to substantiate our findings of psychological distress and enduring depression disease. GGT 
is a useful and relatively more specific tool (compared to ALP and other biliary enzymes) to 
identify alcohol consumption over weeks. Carbohydrate deficient transferrin (CDT) is 
considered a better measure of heavy alcohol use and may serve as a prognostic indicator 
towards abstinence (88).  A combination of CDT measure with GGT gives higer sensitivity 
and specificity towards alcohol intake (89). Ethyl glucuronide (EtG) is a direct metabolite of 
ethanol that can be detected in body fluids for a relatively longer period after complete 
clearance of ethanol from the body (87).  Serum and urine levels of EtG can be useful in 
determining the time of recent ethanol intake making it a useful tool to monitor abstinence 
(90). EtG can also be detected in body fluids, and even hair at very low levels, making it an 
important measure of alcohol intake (91). 
Alcohol is a known modulator of immune system and depression is suggested to cause 
alteration in cytokine profile consequently increasing susceptibility to infection. Independent 
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effects of major depression and alcohol dependence among alcohol-dependent persons on 
immune cell function have been investigated in experimental models (92). The role of AUDs 
as modifier of this relationship is not yet established. This study will extend to establish the 
relative contribution of alcohol-use disorders in the balance of circulatory pro- and anti-
inflammatory cytokines in humans. We hypothesize (in upcoming study, using the material 
collected during this study) that ethnicity moderates such relationship. We intend to compare 
the findings between Nepalese data and data from comparable Norwegian clinical population.   
 16 
 
1.3  RATIONALE FOR THE STUDY 
 
Although many epidemiological studies relating to substance use and psychiatric disorders 
have been conducted in the western world, the methodological applicability and extent of 
generalisability of such studies in the third world context is questionable. So far no 
comprehensive studies have been conducted in Nepal to address the comorbidity associated 
with alcohol-use disorder and other psychiatric disorders. Even less is known about the 
characteristics of the very few patients who actually seek treatment. It is necessary to 
investigate them in order to get insight of the disease epidemiology in population level. 
Absence of pertinent baseline data, phenomenon of treating the patients in this group as 
„miscellaneous‟ and lack of specialized treatment modalities for dual diagnosis patients 
created a ground for this study in Nepal. In addition, the complex socio-cultural attribution 
(including taboo attached with alcohol dependence and depression) and poor health 
economics make Nepal a unique ground for alcohol related psychiatric disorders.  
 
Furthermore, epidemiological transition following the rigorous socio-political transformation 
of the society in the past decade necessitates an observation of psychiatric comorbidity 
against which future findings may be compared. The rationale for undertaking this study are 
simpler than complex. Both alcohol-use disorders and depression are common conditions, 
their share to morbidity and mortality is quite high, and the share of South Asia in non-
infectious diseases (besides infection and malnutrition) has appropriately been characterized 
as a coin of the double burden. The comorbidity of alcohol and related psychiatric illness 
increases the morbidity in geometric fashion. The theoretical and clinical implication of this 
study is manifold. The first step is to scale the extent of the problem and bring in attention 
from stakeholders, mainly the health policy makers and service providers. It is equally 
necessary to contribute to the scientific community by sharing the findings from relatively 
new but naturalistic (in the sense of culturally ambivalent drinking society) setting for 






1.4  Research Questions 2             
                                                                            
1. How prevalent are major depression and anxiety disorders among individuals who seek 
treatment for their drinking related problems in alcohol treatment units in Kathmandu, Nepal? 
2. How are sociodemographic and clinical characteristics related with comorbid depressive 
and anxiety disorders in this population? 
3. Are the prevalence and correlates of comorbid anxiety and depression disorders different 
across two strata of Nepalese society divided by socio-cultural taboo on alcohol use? 
4. How common are nicotine and other substance use among alcohol abusing population in 
Nepal who seek treatment for their problem drinking? 
5. How are suicidal ideation, plans and attempts made by alcohol using population related to 
the alcohol consumption pattern and comorbidity of major depression/anxiety disorders?  
1.5  OBJECTIVES  
1.5.1 General Objective 
To estimate the prevalence of major depression and selected anxiety disorders among alcohol 
abusing or dependent population who seek treatment for their problems associated with 
drinking, and to observe the socio-demographic and clinical correlates of such comorbidity in 
the context of Nepal. To find association of alcohol-use disorders with comorbid 
depression/anxiety, suicidality, and other substance use disorders in alcohol-restricting and 
alcohol-banal divides of the same society. 
 
1.5.2 Specific Objectives  
 To find out the prevalence of major depression among Nepali population who attend  
treatment centres for their alcohol-use disorder.  
To find out the prevalence of social phobia, agoraphobia, generalized anxiety disorders, 
panic disorders, and a history of post-traumatic stress disorders among Nepali population 
who attend  treatment centres for their alcohol-use disorder. 
 To establish how socio-demographic parameters, including age, marital status, ethnicity, 
occupation and urbanity of their place of origin relate with such comorbidity.  
                                                          
2
 Paper I addresses research questions 1-3, considering depressive comorbidity only. 
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 To find out if belonging to a social class that has a taboo against alcohol use is a predictor 
of comorbid depression/anxiety disorders/suicidality/other substance use disorders. 
 To find out if levels of serum γGT, CDT, EtG, EtS, or urinary EtG, among other biological 





CHAPTER 2.  METHODOLOGY 
 
2.1  Overview 
This cross sectional study from one tertiary level hospital and seven alcohol treatment centers 
from central Nepal investigated 188 institutionalized patients with an alcohol-use disorder by 
using comprehensive interview schedules and biological tests to assess anxiety and 
depressive comorbidity. Lifetime and 12-month prevalence rates of major depression and 
selected anxiety disorders comorbid with alcohol-use disorders were estimated. Socio-
demographic and clinical correlates were examined by classifying the population into 
traditionally alcohol consuming community and the community that has social restriction or 
taboo against alcohol use.  
 
2.2  Study technique/design 
The inception of this study was based on positivism. Thus we endeavored to measure 
prevalence of our outcome variables in the background of testable hypothesis that would lead 
to ascertainment of their association with explanatory variables (sociodemographic, clinical, 
and biochemical). We recognize that certain aspect of the study could have been performed 
by a qualitative method, since a vast majority of mental disorders can be seen as a result of 
social construct. An ethnographic approach to understanding the mediatory role played by 
certain factors, such as social taboo, triangulated with epidemiological method could be a 
desirable alternative approach as used by Kohrt and colleagues (22). We were guided by the 
concept that an objective system of measurement generates facts and the hypothesis that 
social attribution has an impact on the rates of depression could be tested (93). Thus, a 
quantitative research technique was chosen in order to quantify the size, distribution of and 
association between the study variables. 
 
The study was carried out with a cross-sectional design. A cross-sectional design is 
commonly used in epidemiological and clinical studies where the measures of interest are 
exposure and outcomes that are measured at a point in time. The study objective favored this 
design due to the fact that current and life time occurrence of major depression and anxiety 
disorders, substance use disorders, and suicidal behavior together with their 
sociodemographic and clinical states could be assessed simultaneously. We intended to 
compile the historical occurrence of the variables of interest at one point in time. This 
retrospection has its own peculiarities, which will be discussed later. Conversely, the study 
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theme could be operationalized and carried out by using longitudinal designs. For example, 
prospective longitudinal study design could be helpful in observing the incidences of 
depression and anxiety disorders over a time span. Similarly, a cohort of pre-pubertal 
children in the study area, for example, could be followed up over many years to observe the 
occurrence of the outcome measures. Given the resource limitations in terms of manpower 
(requiring trained interviewers), time (four and half months available for the whole data 
collection), limited funding pledges (against costly laboratory tests), a cross sectional study 
design was considered the most suitable undertaking. 
 
This study can be regarded as a descriptive diagnostic and analytical study of clinical 
population. The diagnostic measures are aided by the use of fully structured psychometric 
tools. The analytical part is accomplished by analysis of biological/biochemical parameters. 
 
2.3  Sampling 
2.3.1 Study area and population 
The Kathmandu valley is a cultural, political and commercial hub of Nepal with 1.5 million 
inhabitants (8). It represents the urban concentration of the whole country with relatively 
better indices of development. Besides the ethnic Newars, Kathmandu harbors people hailing 
from different parts of the country with diverse religious, cultural and ethnic backgrounds. 
Most of the country‟s specialized health centers are located in the same region. Kathmandu is 
a preferred centre for health care.  
 




According to unofficial sources (official data not available), of some 75 rehabilitation centres 
running in different parts of the country, 25 were operating in Kathmandu valley. We 
conveniently selected one hospital which offered pharmacological treatment and seven 
rehabilitation centers which offered non-pharmacological rehabilitation care from different 
locations in Kathmandu and Lalitpur (Patan) districts (Fig 2).  
 
The department of Psychiatry at the Tribhuvan University Teaching hospital (TUTH) in 
Maharajgunj, Kathmandu ran a „de-addiction ward‟ where patients diagnosed with one of 
substance dependence syndromes were admitted to detoxify them, generally over a period of 
two weeks. Majority of the patients were enrolled either from the Psychiatric outpatient clinic 
or from the Emergency unit.  Some of the patients were also referred from other departments 
at the same hospital. A team of psychiatrists and clinical psychologists provided 
benzodiazepine based detoxification followed by psychological counseling services.  
 
The remaining seven institutions offered residential rehabilitation care for an average of three 
months. Peculiar about these centers was that all of these constituted therapeutic communities 
and no drug was allowed for detoxification purposes. However, most of the centers had 
visiting psychiatrists or general practitioners who, on an absolute need-basis, sanctioned 
pharmacological treatment of chronic conditions including some psychiatric disorders, rather 
than detoxification purposes. Some of the centers provided multivitamin supplement to the 
clients, some even extended psychological counseling services. All centers were run by 
counselors who had either received training or had working experiences in their field for a 
varying duration of time, others were recovering volunteers. Richmond Fellowships Nepal 
(Alcohol) offered rehabilitation care explicitly for alcohol users, whereas Richmond 
Fellowship Nepal (Female) was the only center providing services for female alcohol users. 
Other centres, namely Ashara Sudhar Kendra, Nawakiran Rehabilitation Centre, Prarambha 
Nepal Rehabiliation Centre, Richmond Fellowship Nepal (Male drug unit), and Clear Vision 
Drug and Alcohol Treatment Centre enrolled treatment seeking male substance users- 
including the alcohol users. All the centers were applying the principles of 12-step programs. 
Such establishments required license from the Ministry of health and Social Welfare Council, 
but no official data could be obtained regarding the number of the operational centers.  
 
Of the 11 visited centers, two refused to participate and other two were excluded. Details are 




Patients receiving treatment on outpatient basis were not included because it would be 
ethically incorrect to ask them wait for a length of hours to contribute to the study. It was also 
necessary to create uniformity in the nature of study participants. Selective exclusion of these 
potential participants was not a part of our intention, as highlighted in the study protocol. 
Patients under current influence of any substance as judged clinically were deferred 
enrollment. All potential participants were screened for psychotic features before request for 
participation was made. In order to minimize the overlapping symptoms of alcohol 
withdrawal and axis I disorders, the interview schedule was optimized for a longest possible 
duration of abstinence from alcohol use. No interviewing was done until 10 days of 
abstinence was ensured. Institutional stay length was considered a valid period of abstinence. 
However, one potential participant at the hospital was identified alcohol smell positive, and 
therefore excluded. 
 
No clear difference in socio-demographic characteristics was noted between treatment 
seekers at the hospital and those at the rehabilitation centers. However, patients who 
developed delirium tremens, and more plausibly those with alcohol use related physical 
ailment, were more commonly taken to the hospital rather than to one of the rehabilitation 
centers. The centres for treatment were chosen voluntarily and the service charges depended 
on the patients‟ out-of-pocket expenditure. Inpatient treatment at the hospital for a fortnight 
would cost around 5000 Nepalese Rupees (USD 1 =approximately NRS 72 as of May 20, 
2011), whereas the rehabilitation centers charged between 24 thousands and 36 thousands 
Nepalese Rupees for the 3 month-long residential care. Fig. 3 shows the contribution of 
participants from these centers.  
 
2.3.2 Sample 
The above-mentioned treatment units constituted the study sites; all clients undergoing 
residential treatment at one of these units (and in generalization, other treatment centres that 
resemble these units) with a primary reason for treatment seeking being alcohol use related 
but not primarily physical ailment made the study population; each client meeting the 
inclusion criteria were study subjects. The sampling method can be attributed to clusters of 
sampling units of these treatment centres chosen conveniently, and study participants were 
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inclusive rather than random. The methodological limitations of non-probability sampling 
employed in this study are discussed later. 
 
Fig 3. Sources of patients who agreed to participate (N=204) in the study. Note that 5 patients 
dropped out of the treatment before the interview could be taken. Tuth stands for Tribhuvan 
University Teaching Hospital. All others are rehabilitation centres. 
 
Only four and half months were available for data collection, and the flow of patients meeting 
inclusion criteria in any of the treatment centers in the study area were under 20 at any time 
which compromised the size of enrollment. Thus, convenience method of sampling was 
chosen. This implied visiting several of such centers and recruiting participants as they 
became available. Thus our sample constituted of consecutively admitted patients at the 
treatment units during the data collection period of 17
th
 August and 28
th
 December 2010.  
 
The aim of the study is not to suggest a causality or direction of alcohol-use disorders and 
MD or anxiety disorders which is better approached with a longitudinal study design. We 
wanted to observe the strength of association between various socio-demographic and clinical 
characteristics of the patients that might have bearing in the comorbidity. This did not 
necessitate randomization. Studies like this might be approached with a case control design, 
but since we would also have non-depressed AUD patients, we were left with the possibility 
to observe the differences, for example, between the two groups of depressed and non-
depressed AUD patients. This study hence justifies the method chosen for epidemiological 
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observation of psychiatric comorbidity. We believe that this study would be useful as a 
baseline against which the insights of the gravity of alcohol-use disorders and associated 
comorbidity can be acquired, extending into general population level. 
 
2.3.3 Sample Size and Selection  
No convincing data on proportion of axis I psychiatric diagnoses among alcohol users were 
available from Nepal. Therefore, report of a study but done in American population which 
estimated the 12-month prevalence of MD among treatment seekers with an AUD in the 
preceding 12-month period at 33% was used as a best guess (19). 
A prevalence proportion (p) of major depression among the clients was considered 0.33. The 
target sample size was determined using formula for precision of proportion for the comorbid 
to isolated alcohol-use disorder:  
         
            
  
      
For a 95% confidence interval for p that is expected to be about 33% or (0.33) with a margin 
of error (d) no more than 0.05, the number of subjects (N) required would be 
                  
     
 
 ≈ 340. However, only 199 participants completed the interviews. This would compromise 
confidence interval by 2%. As is frequently the case, studies of this nature suffer statistical 
power.  We argue that the power of the study would be enhanced by its capacity to include a 
majority of the clients that sought treatment. Rather than the number of study participants, the 
strength of this study was in the inclusive nature of participants who represented diverse 
socioeconomic status, ethnic backgrounds, and place of origin. These treatment centres can 
be considered catchment units for the whole country (Fig 4). 
 
All clients present at the institution during the data collection period and who met inclusion 
criteria were successfully enrolled from all the participating institutions except for Ashara, 
Richmond D and Clear Vision rehabilitation centres. The contribution of these centres in total 
participation was under 24%. The supporting staffs at these institutions were asked to make a 
list of available clients and the researcher approached the client in descending order of 
recency of admission. Thus participant selection was inclusive wherever feasible, and 
purposive wherever not feasible, but the basis for selection of study sites was entirely 
convenience. Government authorities were not able to provide data on the number of 
operating centers and patient flow in the institutions of the region; hence sampling frame and 
representativeness of the centres couldn‟t be ascertained. Despite this, it was known that 
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outside hospital settings, Richmond Fellowship Nepal (Alcohol), which made a third of our 
sample, was the sole center in the whole country dedicated specially for rehabilitation of 
problem drinkers. 
 
Fig. 4 Map of Nepal showing all 75 districts. Flagged regions are the districts from where the 
participants originated. Two flagged zones are outside Nepal to represent the country of 
residence in the preceding 5 year period. Scale is not applicable. Map source: World Wide 
Web (95). 
2.3.4 Study groups 
One of the main aims of the study was to observe the difference in the groups in a naturalistic 
setting, where Nepalese society is divided in ambivalence regarding the use of alcohol. Fig 5 
depicts the proportion of the participants who belonged to the alcohol related tabooed group 
(Tagadhari) and non-tabooed group (Matwali). 
                                  
Fig 4. Groups of participants divided according to taboo on alcohol use.  
 
107; 57 % 





2.3.5 Sample attrition/bias 
The method for study sites selection has been discussed in the section Study population. Of 
the visited 11 centers, 2 refused to participate and other 2 were excluded. One center which 
reasoned organizational restructuring for non-participation was found to have 4 patients with 
alcohol use related problems at the time of approach. The centre lied in the vicinity of another 
participating centre. The centre was led by a recovering alcoholic who had undergone (and 
practiced 12-step philosophy himself) at yet another rehabilitation centre included in our 
study. Another centre which pointed confidentiality concerns behind non-participation 
contained 17 patients at the time of approach with unknown share of alcoholics. The director 
of the centre was away at the time of approach. Reattempt for request for participation was 
not done because there were adequate possible samples available for recruitment given the 
resource limitations. There were no obvious differences in the characteristics of the clients at 
these centres compared with the centres from which recruitment was done. But this 
assumption may not be reliable. 
 
One centre was excluded because of its location about 20 kilometers from the laboratory 
where samples were processed - it could not be feasible to process the samples within two 
hours after collection. Yet another center was excluded because it applied a different 
philosophy (Sauna bathing, use of high dose vitamin supplement, and course teaching) and 
the treatment cost was over five times higher than all other centres - thus distinguishing the 
clients from the rest of the sample.  
 
Five participants who signed the consent form dropped out of the rehabilitation programs 
before the scheduled interview dates. Among them were three females who absconded and 
two males who had left against institutional advice. Furthermore, there were 11 refusals for 
participation. Two patients were from hospital; one of them cited disagreement from his 
family, and the other postponed the decision until the discharge. We were unable to follow 
him. There were two other patients at the hospital who met the conditions except for the 
physical inability to participate. All nine clients from the rehabilitation centres who refused 
participation reasoned non-interest. We assume that the potential influence this could make in 
our results were non-significant. The response rate calculated was 95.2%for all requests. 
However, of all considered 221 participants, the participants included in final analysis (188) 
made 85%. 
Biological sampling details are given in a separate section. 
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2.3.6 Eligibility Criteria 
Before recruitment in the study, all the selection criteria were reviewed by the researcher 
himself. Persons who met all the following criteria were considered eligible to participate in 
this study: 
1. Age 14 years or older of any gender. 
2. Written informed consent signed by the client (signature of a witness to confirm 
informed consent together with the thumb prints in case of illiterates). 
3. Be a returning/follow up or new patient admitted with a diagnosis of alcohol 
dependence syndrome or poly-substance dependence syndromes (with alcohol abuse 
or alcohol dependence) at the „de-addiction ward‟ of TUTH, or an in-house client at 
one of the participating alcohol and/or drug rehabilitation centers whose main reason 
for such admission was problem drinking.   
2.3.7 Exclusion criteria 
Persons were excluded from participation in the study even if they met the above criteria if 
they met any of the following: 
1. Unable to complete the interview due to ill health. 
2. Unable/refuse to consent for any reasons. 
3. Under the influence of recent alcohol or other substance use as judged clinically.  
4. Presence of any substance withdrawal delirium (DSM-IV; see appendix).  
5. Disorientation or ongoing psychotic symptoms. 
 
2.4 Ethical Considerations  
Given the sensitivity of the topic, socio cultural acceptability of the questioning, and 
vulnerability of the study population, ethical considerations were given high emphasis. 
Participants were institutionalized individuals for treatment to their problem drinking, either 
brought by self motivation or in compliance with suggestions from care takers, often family 
members. However, the female participants from refugee camps in Eastern Nepal were 
brought with the support of International organization for Migration. 
 
Early in the process of project planning we anticipated several potential vulnerabilities borne 
by these individuals. Among these vulnerabilities included psychological distress as part of 
manifestations of potentially multiple neurotic or psychotic, or both pathologies. A 
subpopulation would be multiple substance users. We anticipated history of criminal 
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behaviour, among other personally sensitive issues. During the recruitment period, it became 
trivial that many of them were socio-economically disadvantaged. Patients with traumatic 
antecedent events with certain diagnoses of anxiety disorders and suicidality might be posed 
to retraumatization due to certain sets of questions. Moreover, participants contributed with 
their time and personal information and also provided blood sample for investigation 
demanding the justification of benefit over potential harm in such clinical researches. We 
employed measures to limit undesirable effects. These measures are discussed further below.  
 
Patient‟s autonomy was given first priority. Written informed consents were taken before the 
interview session started and verbal re-consenting was requested before administration of 
every new instrument. A separate question was placed on the written consent regarding the 
collection of blood and urine samples. The participants got the choice of contributing to the 
study without offering biological samples. The samples alone were not collected since a lack 
of diagnostic assessment would make the samples „orphan‟. The rates of acceptance are given 
in the materials section. All voluntary participants were informed of possible risks and 
benefits of participating in the research in clear and comprehensive tone at least twice. We 
conducted group sessions at the institutions where the principal investigator discussed 
relevant clinical aspects of addiction and responded to questions raised by the clients. This 
comprised of lecture on the biological domain of addiction, its entity as a disease 
phenomenon, possible effects on the body and the treatment. The same opportunity was used 
to invite them for participation in the study. However, group sessions were not possible in the 
case of hospital due to short treatment duration (2 weeks or less) and low occupancy rates (5 
or less number of clients at any given time during the study period). These patients received 
invitation for participation before the interview was scheduled.  
 
All the interview sessions were timed and a refreshment break was made after 45 minutes if 
the questioning was not yet complete. Wherever a separate appointment was made for the 
interview, reimbursements were offered for transportation costs limited to a maximum of 
Nepalese Rupees 250 (1 Nepalese Rupees as of May 20, 2011= 0.014 American dollars). We 
weighed this would not amount to aggravating risky behavior or manipulative phenomenon 
because it was minimal, was supplied as reimbursement and paid as an expense incurred for 
the sake of participation. Participants received free general physical examination after the 




All maneuvers, including physical examination, and the venepuncture for blood sample 
collection were done at the presence of the duty manager or counselor at the institution. But 
interviewing was done in privacy except in case of three female participants who upon 
inquiry chose to have an attendant beside. Those participants were accompanied by a 
supervisor at the institution during interviewing. There was, however, also a male participant 
who wished to be accompanied by his wife during the interview; this request was accepted.   
 
The use of alcohol and other illicit substances in the society constitutes sensitive personal 
information and might potentially trigger judgments on an individual‟s behavior which could 
be detrimental to his/her social wellbeing. As the questionnaire involving depression, anxiety 
and suicidality might cause discomfort to the participants, utmost care was given not to 
overwhelm them from the questioning. The modules with sensitive questioning especially the 
suicidality section of CIDI were carried out towards the end. Three participants showed 
emotional outbursts, hence the interviewing was stopped. They opted to complete the 
questionnaire in the next session, which was then planned in their convenience. 
 
For participants leaving the direct observation of clinician within the day of the interview 
session was evaluated and consulted with the attending or a duty clinician/psychologist 
before discharge. All the participants were assured the option of quitting the session any time 
during the interview. Any question that the participant did not feel like answering was given 
option to skip. Moreover, confidentiality and privacy of any personal information and their 
mental integrity as highlighted in the declaration of Helsinki (96) were respected. Data 
handling procedure is discussed in a separate heading in the methodology section. 
 
All the interview sessions took place in a private cell ensuring confidentiality, safety and 
comfort. In addition, relevant counseling was provided at the end of the session to the patient 
who sought medically pertinent information. This dual role as a researcher and a clinician 
was however balanced by not making any prescriptions. 
  
Another important ethical consideration to be made in the study was anonymity. For 
participants who wished to be contacted for results of the study required their contact details 
to be recorded. The investigator did so by coding in the response forms which could be 
decodable only by him whenever necessary. Each participant was given a unique identity 
number, and personal identification details were placed separately.  All the response forms 
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were stored by the researcher at his residence during the data collection period. Later, all the 
response sheets were brought on hand luggage with the investigator. All paper data were then 
locked up at SERAF, the consent forms were stored at a separate locker at SERAF.  
 
The serum samples were consequently destroyed after the aforementioned investigations. 
One set of serum samples are still being preserved with the extension permission from the 
relevant ethical review boards. These samples will be analyzed together with samples from 
Norway for investigation of serum cytokine levels. Details are given in the section Biological 
parameters. 
 
The ethical consideration was thus in compliance to the following principles set by 
internationally recognized guidelines for the ethical conduct of medical research with 
humans: autonomy, non malfeasance, beneficence, and justice (97;98). 
2.4.1 Ethical Review 
Before the start of the data collection, the ethical review and clearance were obtained both 
from Norwegian regional ethics committee (REK) Region South-East and Nepal Health 
Research Council (NHRC). The institutional review board at the Tribhuvan University 
Teaching hospital was also applied for ethical review. The committee failed to provide such 
an approval owing to complex nature of the study in concern, but validated the review from 
the NHRC which is the governing body of all institutional review boards in Nepal. Since we 
intend to include the Nepalese data for cytokine testing, we applied for extension of retention 
time for the biological specimens, an application was sent at the REK, which has extended 
the date for three years (see appendix). 
 
2.5 Assessment 
2.5.1 Psychometric Instruments 
A myriad of tools have been developed to diagnose and measure severity of psychiatric 
conditions. Choice of the tools was made with consideration of earlier use, validation done in 
the population in concern and the circumstance of their use in research. Self Reporting 
Questionnaires (SRQ) have been used in various settings to screen effectively mental 
symptoms in the community but it will not be practical in this population because the average 
 31 
 
literacy rate of Kathmandu which was among the highest in Nepal is at 83% (8). The tools 
used in the present study were structured diagnostic interviews or screening tests for harmful 
alcohol use and mental distress. 
The following tools were used in course of this study. 
1. Hopkins Symptom Checklist-25 (HSCL-25) Nepali version: This was initially 
developed by Derogatis et al. in 1974 and has been used widely in different settings as 
a measure of psychological stress (99). This is a screening questionnaire with 10 items 
on anxiety and 15 on depression symptomatology. All items have 1-4 response set to 
evaluate their anxiety and depression status. The scoring is done on each answer 
according to the frequency of symptoms experienced (1=not at all, 2=a little, 3=quite 
a bit, 4=extremely). The anxiety and depression scores are average scores of all items 
divided by the number of items within the respective subscale (10 on anxiety and 15 
on depression), with higher scores indicating greater mental disturbance from anxiety 
and depression. The HSCL-25 has previously been validated (33) and used for the 
Nepali population (33;100). In the present study, answers were marked for all the 
questions, but two questions in the depression module were excluded from analysis 
due to high rates of acquiescence responses. These questions dealt with blaming 
oneself for all kinds of mishappenings, and feeling of being trapped or caught in 
something, probably germane to the in-treatment substance users as participants. 
 
2. Alcohol-use disorder Identification Test (AUDIT): The AUDIT was developed by 
WHO as a simple method of screening an individual with three questions about 
hazardous alcohol use, three about dependence symptoms and four about harmful 
alcohol use (101). It is scored as 0-4 with 5 answers on first 8 questions with higher 
values representing higher frequency. The last two questions, alcohol related injuries 
and others concerned about drinking, are responded as 0(no), 2(yes, but not in the last 
year), and 4 (yes, in the last year). This tool has enjoyed widespread use in clinical 
and research settings, including demonstrated psychometric properties in a similar 
population (102). It was also used in earlier research in Nepali language, in clinical 
and research settings.  Research has been conducted in a wide variety of countries and 
cultures suggesting its applicability as an international screening test (101). The 
average score of 8 and above has been identified as cut off level for both sexes as 
alcohol problems; 8-15 medium level of alcohol problems and ≥16 is high level 
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alcohol problems and ≥20 possible alcohol dependence warranting specialized 
evaluation (103).  
 
3. Timeline Follow back (TLFB-Alcohol): First coined by Sobell et al. (104),  the TLFB 
is a method for assessing recent drinking behaviour by asking clients to 
retrospectively estimate their daily alcohol consumption over a time period ranging 
from 7 days to over 24 months prior to the interview. The tool is useful in examining 
variability (i.e., scatter), pattern (i.e., shape) and extent of drinking (i.e., elevation; 
how much) (104). A Nepalese calendar from the last 30 days was used to assess the 
drinking behaviour. Quantification of drinks was made by using a chart for different 
kinds of drinks on use in the locality (see also definition section for unit 
measurement). The reason for using this tool was to substantiate the findings of 
biological parameters: in order to observe the correlation between the GGT, CDT, 
EtG levels and the pattern of alcohol use in the past weeks. 
 
4. Composite International Diagnostic Interview (CIDI) (105) version 2.1 (Nepali): This 
is fully structured comprehensive interview to be used by trained interviewers for the 
assessment of mental disorders according to the definitions and criteria of 
International Classification of Disease (ICD-10) (106) and DSM-IV (107). The 
modules used in this study have shown acceptable reliability and validity in a number 
of studies across a wide range of cultures (108;109). The investigator who also 
received training for its use carried out the interviews. The tools have been previously 
translated into Nepali using standard procedures (84) and used previously among 
Nepali speaking Bhutanese refugees in Nepal (34). The following sections of CIDI 
were administered:  
a. Alcohol Use (AU) 
b. Illegal Substance Use (IU) 
c. Depression (D) 
d. Agoraphobia (AG) 
e. Generalized Anxiety Disorder (G) 
f. Panic Disorder 
g. Post-traumatic Stress Disorder (PT) 
h. Social Phobia (SO) 




5. Investigator formulated question for measurement of satisfaction with the offered 
treatment were administered at the end of the interview session. It included a separate 
questionnaire recording chronic illnesses, significant medical/surgical history, and 
smoking history- both lifetime and current (see appendix). Demographics section 
included one extra question that asked about availability of significant other who 
could offer moral, economic or logistic support when sought (answered as inadequate, 
some, adequate). 
2.5.1.1Preparation of tools: While all other sections were used from available Nepalese 
versions of CIDI, the two sections, Suicidality (SD) and Illegal Substance Use (IU) were 
extracted from English version of CIDI 2.1. The standard guideline for the translation of 
these tools was followed, and the procedure was repeated as mentioned elsewhere (84). In 
short, SPN translated the questionnaire into Nepali. Another non-psychiatric specialized 
medical doctor back translated the forms into English. This was reviewed by an expatriate 
mental health researcher and Psychiatrist who had worked extensively with transcultural 
psychiatry, had used CIDI earlier with Nepalese people. He identified and suggested 
amendments were discussed to make the final version. This process was done for two section, 
i.e Suicidality and Illegal substance use only. A repeated focus group discussion for 
increasing the understandability of these questionnaires as suggested (84) could not be done 
because we anticipated heterogeneous group of people in terms of culture, ethnicity and 
language of daily use. 
All the psychometric tools were pen and paper version and administered in Nepali language 
except in case of one patient who chose to be interviewed in English since he was non-native 
Nepali speaker. Multiple tools were used in order to increase the accuracy of the 
corresponding measures and to substantiate the findings of other tools.  
2.5.1.2 Pretesting of the tools: Pretesting was done in the first month of field visit while 
waiting for the approval from the review boards. The whole batteries of instruments were 
pretested on two patients from the hospital, and 3 from one of the rehabilitation centres who 
would meet criteria for inclusion. The questionnaires were modified according to the 
observation from pretesting. Questions that returned high rates of acquiescence responses 
were dropped from analysis only.  
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The psychometric instruments used in this study are attached in the appendix. CIDI 
questionnaires are not found in appendices because of copyright permissions limited to 
WHO. 
2.5.2 Biological Parameters 
A number of biomarkers have been investigated in an attempt to verify objectively the history 
of alcohol use especially in recent past. Since it is necessary to complement the accuracy of 
the psychometric tools, in diagnosing and characterizing alcohol-use disorder, the following 
laboratory analysis were carried out in the study subjects: 
 Serum analysis 
1. Carbohydrate deficient Transferrin (CDT) 
2. gamma-glutamyl transferase (GGT) 
3. Ethyl glucuronide (EtG); Ethyl sulphate (EtS)- reporting awaited 
Urinalysis 
1. Urinary pH 
2. Urinary Creatinine 
3. Urinary EtG  
 
Other serological tests were planned in connection to an evolving research project DARCY. 
This study will investigate the differences in the cytokine profiles of depressed and non-
depressed substance users against the healthy controls. The tests include pro-inflammatory 
cytokines: IL-1, IL-6, TNF-α, and INF- γ. Anti-inflammatory cytokines considered are IL-4, 
IL-10, and IL-12. This was planned at the early phase of the current study in which we 
attempt to find the ethnic differences (Nepalese and Norwegian samples) in the relative 
balance of pro-and anti-inflammatory cytokines in the backdrop of AUD-MD comorbidity.  
2.6 Socio-demographic Characteristics of study population 
To answer question regarding the socio-demographic correlates of the outcome variables, a 
separate questionnaire (modified from demographics section of CIDI 2.1) was formulated by 
the investigator and administered at the start of the interview session. The characteristics 
noted were as follows. 
a. Gender: Male/Female/Other 
b. Age: noted in scale; further stratified on groups: 14-22/23-35/36-55/ 56+ 
c. Urbanity of origin: urban/rural  
d. Urbanity of residence: urban/rural  
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e. Ethnicity/Caste: Dichotomized into Matawali or Tagadhari noting Brahmin, 
Chhetri, Newar, Tamang, Rai/Limbu/Gurung, Sherpa, Madhesi or other and 
confirming with the participants whenever not obvious. 
f. Marital status: Never married/married and cohabiting/ divorced or  living 
separately or widowed /other 
g. Type of family (Nuclear/Joint/Extended) and number of children  
h. Education : Highest level of education attained:  none, some school (up to 7 years 
or attended adult education), secondary (8-12 years), University 
i. Occupation: unemployed/cottage industry/ farmer/service (private or government 
firms)/own business/labourer/foreign employment/drivers 
j. Social support (moral and/or logistic when needed): none, some, Adequate. 
k. Significant other (if any: relation to the participant) 
Of the 198 completed interviews, almost 90% were males and less than 15% were hospital 
attendees. Patients were aged between 14 years and 64 years with a median age of 35 (SD: 
10.1) years. Over two third of the sample was aged between 24 and 44 years. There were 
about 29% born and living in rural areas, wheras 55% were urban dwellers. About 15% of the 
participants had moved from rural to urban location for at least past 5 years. A half of the 
sample, 97 were based outside the Kathmandu valley; 18 (including 10 Bhutanese refugee 
women) were foreign born. Nine were repatriates. In all 108 (55%) of the sample belonged to 
upper caste Brahmin or Chhetri, followed by Newars (41) and Mongoloids (36). Fortyeight 
participants had never married, 28 were divorced or living separately, whereas the rest (62%) 
were cohabitating in marriage. Two third (128) of the participants were parents. As many as 
57 (28%) had less than 7 years of formal education -of them 16 were illiterate, 37 (19%) were 
university graduates. One hundred and eleven (56%) were living in a nuclear family setup, 
while 13 (7%) reported their family as broken or living alone. A half (96) of the participants 
had a stable source of income (white collar job or own business), 18 were students and 
another 32 were unemployed, 30 were driver, unskilled laborers or returnee from foreign 
employment. Almost a third (62) had below average income levels, and 54 of them reported 
of not receiving adequate social support in terms of moral, economic or logistics when sought 
for.  
2.6.1 Alcohol use related characteristics: A majority of the sample (N=107; 54%) self 
identified as belonging to the social class that has taboo on alcohol use (Tagadhari). Locally 
brewed Raksi was the most preferred drink (47%) followed by sealed spirits (43%); less than 
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10% reported beer, wine or locally fermented Jand or Tongba as drink of choice. The mean 
career of habitual drinking was 16.8 years (SD 9.8). Nearly three fourths of the sample 
admitted of drinking 4 or more days per week; only 5% admitted drinking monthly or less 
frequently. About 75% had used alcohol as eye-opener sometime in their drinking career, and 
60% had experienced alcohol-induced blackouts. 
  
2.7 Definitions and Variables 
 
2.7.1 Definitions  
Definitions of all the diagnoses were made according to DSM-IV or ICD-10 criteria. Cutoff 
values, whereable applicable, were defined according to standard recommendations for 
respective tools. Our main outcome variables were measured as alcohol abuse, alcohol 
dependence, major depressive episodes (life time/ past 12-month), social phobia, 
agoraphobia, panic disorder (with or without panic disorders), general anxiety disorders, post 
traumatic stress disorders, and suicidal ideation/plan/attempt (lifetime/past 12 month/current) 
as shown on table 3. Measures of ethanol concentration and units were contextualized with 
the help of translated version of CIDI section J, where the available drinks were standardized 
during the preparation of the instruments in 1997. Unit measurements of locally available 
drinks were operationalized as under: 
 
Beverage type Volume/Concentration Units of Alcohol 
(standard drinks) 
Beer 1 bottle  (650 ml) ~3.5-5% 
1 can (330 ml) 
2 
1 
Wine 1 glass (100 ml) ~12% 1 
Vodka/Rum
§
 1 quarter 4 
½ bottles 8 
1 Full (1 bottle of 750ml) ~40% 16 





 1 glass (0.2L) (?~20%) 




Table 1. Alcohol units operationalized according to beverage type *=Local fermented drinks 
(usually as food item) 
# 
=Locally distilled drink; 
§
= calculation not compatible with neat 
drinks. 
 
2.7.2 Dependent Variables 
Variable Measure  Source 
Alcohol-use disorders 
 Alcohol abuse 
 Alcohol dependence 
CIDI (section J, alcohol 










Major depressive episodes 
Average Score from 
HSCL-25  
 (1.75 for both genders) 
(33) 
 
CIDI depression  module 










 Social phobia 
 Agoraphobia 
 Panic disorders 
 GAD 
PTSD 
Score from HSCL-25  










CIDI PTSD module 









CIDI core version 2.1 Nepali (WHO) 
Substance use disorders CIDI (Illegal substance 
use) 
CIDI core version 2.1 Nepali (WHO) 
Suicidality 
 Lifetime ideation 
CIDI suicidality module CIDI core version 2.1 Nepali (WHO) 
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 Lifetime plan 
 Lifetime attempts 
 12-month ideation 
 12-month plans 
 12-month attempts 
 
Table 2. Dependent variables ; PTSD= Post-traumatic stress disorder 
 
 
2.7.3 Independent Variables 
Variable Measure Source 
Demographics 
 
Age, gender, Ethnicity, Urbanicity, marital status, 
family type and size. 
Created for study 
Education Highest level of formal education attained (none, 
adult education/ some school (upto 7 years), 
secondary (8-12years), University) 
Ordinal scale 
created for study 
Employment Type of occupation (unemployed/cottage industry, 
farmer/service (govt./Pvt.), own business) 
Nominal scale 
created for study 
Social support Availability of  People close enough to support 
(significant other): family/ relative/organizations 
morally and/or logistically when needed. 
Ordinal scale 
created for study 
General Health Chronic illnesses (Yes/No, particular) 
Surgeries under GA* (Yes/No, particular) 





Ambition in life (Yes/No, particular) 
 
Created for study 
Problem drinking 
in first or second 
degree  relative 
(Yes/No, relation(s)) 
 
Created for study 
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1. Carbohydrate deficient Transferrin (CDT) 
2. Gamma glutamyl transaminase (GGT) 
3. Ethyl glucorunide (EtG)-reporting awaited 
 
Urinalysis: 
1. Urinary pH 
2. Urinary Creatinine 
3. Urinary EtG  
 
 




2.7.3 Other explanatory variables 
Alcohol consumption Days in last 30 days: consumed 






      
Medium level alcohol problem 
 
High level alcohol problem 
 
Possible alcohol dependence 
A total score of 8 + on AUDIT 
to identify hazardous and 
harmful drinking 
8-15 on AUDIT 
 
≥16 on AUDIT 
 








2.8 Data Collection  
Data were collected using standardized interviewer-administered surveys. The investigator 
who had also experiences of clinical practice in the same area and had undergone training 
from an authentic WHO CIDI trainer in Norway conducted the interviews. Expertise on the 
administration of the psychometric instruments were ensured by practical exercises at 
Innlandet hospital trust, Sanderud, Hamar and the Norwegian centre for addiction research 
(SERAF) before field trip.  
2.8.1 Recruitment 
The researcher visited the hospital every working day. He checked the patient register for 
potential participants, who were then approached personally at the „de-addiction unit‟ of the 
hospital. The researcher introduced himself according to the details mentioned in the 
beginning of consent form (appendix). They were checked for capability to consenting by 
reviewing patient history form and repeating the orientation (to time/place/person) status. If 
so found, request for recruitment into study was made, eligibility criteria were reviewed, and 
study procedures were explained and risks and benefits were discussed as part of the 
informed consent process.  The consent form was then read aloud, they were asked if they 
understood clearly about what participation in the study would entail and if they had further 
queries. Any misunderstanding was clarified. 
The samples were then collected. Subsequent visits were made to the hospital where the 
treatment progress was reviewed and an interview date was scheduled no less than 10 days 
since last drink. This implies that collection of blood and urine sample was done at the first 
instant and interviewing done at a later data when patients generally improve general 
condition, emotional stability, and co-operation. 
In case of the rehabilitation centres, the researcher allotted Thursdays and Fridays for 
Richmond Fellowship Nepal, and made telephone calls to the rest of the centres to know if 
potential patients were available at the centre, and the centers were visited according to the 
availability of potential participants. The list of available patients was provided by program 
managers at each of the centres. This followed approaching the client by the researcher and 
rest of the recruitment process was same as employed for the hospital. Blood and urine 
samples were collected at completion of all interviews for the day in order to effectively 
process the sample within two hours of collection, following the guideline of the procedure 




The interview took place in a private space to maintain confidentiality and maximize the 
comfort and willingness of the participant and in order to obtain honest and accurate 
responses. Names were not written on questionnaire but were kept on a separate folder of 
consent forms. All subjects were identified by an anonymous study ID and blood/urine 
samples were given unique number that was related to the patients‟ details.  Names were 
associated with their corresponding study ID only. One interview session took no more than 
two hours.  The interviewer read the questions to the participant taking into consideration the 
low literacy rates. The records of the identification were kept by the investigator with 
confidentiality. This was necessary for contacting the participants in course of follow up 
study, and in compliance with ethical review board‟s approval.  
2.8.3 Collection of specimen, processing, storage and transport  
The researcher himself collected blood and urine samples from every consenting participant. 
Venepuncture was defined as failed when no yield of blood more than 1 ml was obtained 
despite 3 attempts. The collection procedure involved the following: 
1. Labeling of samples: All the test tubes and collecting vacutainers were labeled prior 
to collection with a water resistant unique identity sticker matched with interviewee 
reference number. 
2. Participants were given a clean polyethylene jar for collecting mid stream urine and 
were instructed to transfer about 4 ml of the collection to a polypropylene tube 
(Sarsted, Germany. Ref. 60.550.115). 
3.  After applying tourniquette to either arm, antecubital fossa was prepared with 
rectified spirit swab. Venepuncture was done on median cubital vein with BD 
vacutainer 21G*1.5” (0.8*38mm) sterile needle. About 6 ml of blood was collected 
on a BD vacutainer (yellow cork, 8.5 ml gel tubes, BD Ref. 367953) sterile tube. 
4. Sample was mixed by gently tilting the tube up-side-down for 6-8 times and 
transported to the biochemistry laboratory at the Tribhuvan University Teaching 
Hospital. 
5.  It was centrifuged after a time lag of 30-150 minutes at a swing-out analog centrifuge 
(CT6T Bench-Top Versatile Centrifuge (Licensed from Hitachi) (CT6D Export 
Model) at approx. 1300 g for 12 minutes. 
6. Clear serum was transferred into three polypropylene tubes (Sarsted, Germany. Ref. 
60.550.115), each with 1ml, using a burette and a clean burette tip. In case of 
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hemolysed serum, it was transferred to a fresh tube and centrifugation repeated for 5 
minutes. The tubes contained no preservative. 
7.  The serum and urine samples were frozen at around -20 degrees at the laboratory 
freezer compartment that was ensured with an uninterrupted supply of power. 
8. Sample was packaged with UN packaging standards and transferred through air 
courier in two batches using dry ice. Refilling of dry ice was done on arrival in Oslo 
airport and samples were delivered, in both instances, within 24 hours travel time to 
the laboratory at the Norwegian National Public Health Institute in Oslo.  
9. The received samples were transferred to the respective laboratories, by the researcher 
himself, and frozen at -20 degrees or below before analyzing.  
 
2.8.2 Specimen details: 
A. Urine for analysis at Fürst laboratories: 196 (Males: 172; Females: 24) 
Missing total: 8 (Refusals: 5, lost to follow: 2, drop out: 1)  
 
       B. Blood: 192 (Males: 168; Females: 24) 
                          1. Serum for cytokine analysis: 192 
                           2. Serum for FHI (EtG/EtS): 191 
                           3. Serum for Fürst laboratories (GGT, CDT): 190 
 Missing total: 12 (8 samples missing same as for urine; 2 more refusals, 2 failed 
venepuncture, 1 avoided due to anxious patient). Note that several samples of 
collected blood were insufficient to give 1*3ml serum yield. 
 
2.8.3 Methods of laboratory analysis: 
 
The method of analysis for the performed test is described briefly due to the length. 
Details were achieved. 
1. Urine EtG: machine: Olympus; specification: 03-05-Olymp; instrument: Olympus 
AU680; estimation by DRI Ethyl Glucuronide calibrator.  
2. Urine pH: machine: Olympus, specification: 03-05 Olympus; instrument: AU680 
analyzer; measured by Olympus AU680 default pH-detector, calibrator pH4 and pH9, 
default calibrators set at NIST pH=7.0 and pH=10 standards. Photometry. 
3. Urine creatinine: machine: Olympus, specification: 03-05-Olymp; instrument: 
Olympus AU680, measured by: creatinine-detector calibrator, Microgenics. Photometry. 
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4. Serum CDT: machine: Olympus; specification: 03-05-658; measured by capillaries 
non-automatized. Capillary electorphoresis.  
5. Serum GGT: machine: labcell; specification: 03-05- Advia 2400 and 03-05-LabCell; 
measured by Advia 2400; use standard: permanent systemfactor. Photometry. 
 
2.9 Data Management  
2.9.1 Data handling 
Immediately following the completion of an interview, the interviewer double checked the 
questionnaire for completeness and consistency of answers. All collected data were checked 
on a weekly basis to rectify the collection method to be used on the following days. Data 
entry were planned to be done concurrent with data collection. But this could not happen due 
to lack of regular electricity supply in the field and time constraints.  
 All the answered questionnaires were stored safely by the researcher himself at a locked 
cabinet in his house. Nobody was given access to any of the data. The researcher himself 
brought the questionnaires to Norway as his hand carriage. The entire set of data was then 
stored in a fireproof cabinet at the Centre for Addiction Research (SERAF) in the university.  
The biological specimens were destroyed after completing the first set of the analysis at the 
Fürst laboratories. The time extension for possession of the data (remaining sets of serum and 
urine samples stored at FHI and Inlandet hospital in Hamar, Norway) has been received and 
detailed in section with ethical consideration. 
2.9.2 Data coding into electronic form:  
All the answers in the questionnaires were coded into a single PASW version 18 data set. 
This comprised of 617 variables and a total of 122166 data points. A data codebook was 
maintained to transfer all collected details into the dataset. Whenever a data did not confer to 
numerical or nominal classification, a new string variable was created to enter in an 
understandable manner. All CIDI dichotomous replies are coded in the questionnaire as 5 
(yes) 1 (no). The same was used in the code book for CIDI and other variables with 
dichotomous responses. Appropriate labels were given to relevant variables. All the data were 
entered twice and checked for consistency between the entries. A discordant set of entry was 
checked for correction. The questionnaire was retained until data cleaning was performed so 
that abnormal data could be rechecked.  
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Personally identifiable details were recorded in a separate spreadsheet. Then all the hard 
copies of the data were stored safely at fireproof lockers at SERAF. 
2.9.3 Editing categories (Recoding) 
The variables were checked for distribution of data and further rearranged and coded 
accordingly. The collected data belonged to either strings, nominal or ordinal categories or 
continuous categories. Some variables such as problem drinker relative were coded as 
nominal descriptive as „father‟ or „mother‟ or „sibling‟ or „second degree relative‟. These 
were recoded into variables that dichotomized the entry into presence or absence of the 
phenomenon. The phenomenon of interest was recoded as 1 and absence as 0 in all cases. The 
CIDI entries containing responses were thus recoded for uniformity as 1(yes) and 0(no) 
respectively. 
Age was kept a continuous variable, but newer variables were created to recode into ordinal 
categories of 14-24, 25-34, 35-44, 45-54, and 55-64. Yet another variable was created for 
younger and older age group dichotomized at the median age of 36 years. These variables 
were analysed/treated according to the needs. In case of depressive comorbidity, we used the 
dichotomous variable to observe the difference between the younger and older population. 
Initially, the place of origin and residence was recorded. Then these were translated into 
urban and rural settings by asking the participant. Finally, the variable was given 4 
categories: 1. Urban origin and residence. 2. Rural origin and residence. 3. Urban origin and 
rural residence. 4. Rural origin and urban residence. The marital status was recoded into 
cohabitating marital relations or other. There was no premarital cohabitation. Family type 
nuclear was considered protective for most outcomes, so it was dichotomized as nuclear or 
non-nuclear. Several occupations were collapsed into two categories, one those having a 
stable source of income and the other without. Stable source of income was coded for all 
white collar job holders, regular staffs at businesses, and those running own business. 
Medium and higher income levels were collapsed together to differentiate from low income 
people set at the least annual pay scale at government firms (Nepalese Rupees 60,000). 
Education below 7 years of regular schooling and illiterates were coded as low education. 
Similarly, treatment centres were categorized as hospital or rehabilitation centres. Preferred 
beverage was classified as locally brewed (including ferment Jand and distilled Raksi) and 
industrially brewed spirits. Drinking frequency was dichotomized as those drinking less 
frequent than 2-4 times monthly or otherwise. A possible „J‟ shaped relationship between 
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frequency of drinking and other outcomes could be overlooked by such dichotomy, so initial 
entries of frequency of drinking was preserved. 
For all variables that required calculations, such as average HSCL, AUDIT scores, a newer 
variable for the calculated results were created. Calculations and categorization according to 
diagnostic criteria was done carefully and double checked for the correctness of the process. 
2.9.4 Data analysis 
All analyses for the interview data were performed using the Predictive Analytics SoftWare 
(PASW) Statistics version 18.0 (SPSS Inc., Chicago, IL, USA). For all the tests statistical 
significance were set at the 0.05 level, and two tailed significance levels reported. Data were 
dealt according to their type (numeric, date, strings), and measures (scale, ordinal and 
nominal). Whenever available, scale values were preferred for analyses. Data were first 
screened and cleaned according the directions of SPSS guide (110). Data were first explored 
to observe descriptive features in terms of mean, median, mode, standard deviation, minimum 
and maximum values, range, percentage, etc.).  Each variables of interest were explored 
according to their type (i.e, continuous, categories). All missing data were carefully checked 
for. Symmetry of data distribution was checked with skewness test on descriptive analysis. 
For missing data in relation to diagnosis, we ignored missed data whenever available data 
met criteria for diagnosis. But if the available data that did not meet diagnostic criteria and 
any variables that would contribute to reaching a diagnosis was missing from the data set, we 
excluded the particular data from analyses. For our first paper, only one case fell into this 
category. Normality of continuous data distribution was tested by running Kolmogorov 
Smirnov statistics described in the manual (110). Extreme values lying outside the whiskers 
in boxplot were considered outliers in case of scores and were excluded from analyses. 
Chi squared test and Fischer‟s exact test were utilized to investigate group difference in case 
of categorical variables. Most analyses presented in the table 1 of our first paper are results of 
chi square analyses. A two by two contingency table was created in order to observe most of 
the categories because it was easy to observe the distribution of our variables of interest. 
Student t-test and ANOVA in case of normally distributed variables and Mann-Whitney U 
test in case of abnormally distributed variables were performed. Dichotomous dependent 
variables were looked for their association with dichotomous or multiple independent 
variables by running binary logistic regression analyses. Explanatory variables that showed 
significant group differences were fitted in separate models to control for each other and the 
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adjusted Odds ratio were reported that spelled out the strength of the association.   Further 
analyses were performed according to the nature of desired result in question. 
Analytical process regarding the biological specimens has been detailed in a separate section. 
Analytical tools used in the first article have been described in the paper. 
2.10 Limitations and strength of the Study 
Due to the constraints of resources in terms of duration for data collection (which lasted 130 
days) and human resource to interview (needing training for administration of CIDI 
interviews) it was not plausible to include a larger sample for study. In order to prevent 
misclassification of acute alcohol intoxication or withdrawal features as affective symptoms, 
duration of 10 days of alcohol free interval was ensured. Despite this, abstinence period of 30 
days were not possible in about 32% cases, which according to several literature, is a period 
where such symptoms may overlap, and observed in Nepal (66).  
There were other limitations of the study: This study did not intend to address the question of 
the causality nor the order of affliction of alcohol-use disorder and other common mental 
illnesses.  Although a large set of data was collected, we could not record the parental 
depressive history. This is because we believed that it would be very non-specific record of 
data. As mentioned in another article, Nepalese people do not take note of things in exact 
dates and numbers (111). We cannot ensure the age of the participants to be their real age; we 
anticipate an error of up to 5 years even in the record of it. There was no verification 
available for the same. In the same terms, the record of drinking history in the timeline follow 
back may be even less accurate. Although, a number of prominent centres of alcohol 
treatment have been successfully engaged, these may not represent the total treatment seeking 
population throughout the country.  
Yet another limitation of the study could be that we could not complete performing analysis 
so far from all the collected data meant for this Masters degree.   
Strength of the study: Despite the limited human resource for data collection, we were able 
to collect quite a large data set of 199 individuals. Moreover, multi-centred involvement 
made the sample more inclusive. We do not regard underrepresentation of females in our 
study because virtually all females who attended treatment in Kathmandu valley during the 
data collection period were successfully enrolled because of a single catchment unit. This 
study is unique in terms of the area and population of the study. Moreover, the collected data 
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constitutes manifold details of explanatory and outcome variables. We believe that it will 
provide citable inferences regarding the dependent variables studied in the region.  
The collection of blood and urine samples was strength to this study. Several findings such as 
concentration of alcohol metabolites will help triangulate the observations. The cytokine 
analysis will help substantiate our findings, and aid in our effort to check the alteration in the 
intricate balance between pro and anti-inflammatory cytokines.  
2.11 Methodological Considerations 
Results and discussion are beyond the scope of this thesis. However, relevant methodological 
considerations in terms of its limitation, strengths and possible sources of bias and 
confounding are discussed briefly. 
We used a cross-sectional study design to estimate the prevalence of comorbid major 
depression and anxiety disorders among AUD patients. This design does not provide 
inferences regarding cause and effect. Neither does it provide the chronology of the disease 
pathology objectively. More specifically, we would not be able to ascertain whether AUD or 
MD was the primary pathology among co-morbidly depressed AUD patients. However, 
prevalence rates and associated factors for the comorbid MD could be efficiently identified 
and their strength of association estimated.  
Methodological Limitations: Not all of the participants were free of alcohol for a minimum 
of 4 weeks before assessment, which might have caused erroneous recording of alcohol 
induced withdrawal features as anxiety and depressive symptoms. This ambitious project 
walked through a double-edged sword in the sense that we needed short abstinence period for 
accurately observing alterations in biological parameters, while at the same time, we needed 
adequate abstinence period for excluding short-lived alcohol induced symptoms.  Secondly, 
the participants despite making a common cohort of treatment receiving in-house clients were 
more heterogeneous than similar. It is extremely difficult to generalize that the same stressor 
(for example, originating from urban areas) could produce effect of same nature or in the 
same direction (for example, depressive outcome). To add on this, we could only assume that 
numerous explanatory factors competed against each other in their risk to cause the same 
outcome. 
This study could not enroll all patients with AUDs even all of the treatment seekers at three 
of the participating units. This made the sample neither representative nor totally inclusive. 
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We were left with a smaller sample size for subgroup analysis. Both type I and type II error 
cannot be ruled out. Another important limitation of the study was that we did not record 
whether the treatment sought at that particular visit was first or subsequent. Given the likely 
fact as suggested in a paper, Nepalese people may not keep track of time or duration. This 
was not only the challenge for appropriately screening duration of low mood; some of the 
participants were not sure about their age. We tamed the presupposition that we would be 
unable to determine whether problem drinking or low mood was the index case. Besides, we 
missed the opportunity of recording the parental depression. 
Methodological strength: Our sample was inclusive and quite large given the resource 
constraints. We applied reasonably robust and validated assessment tools. The response rate 
was very high and dropout was very low. It was owing to our careful planning regarding the 
selection of time for specimen collection, and interviewing together with co-ordination with 
the participating centres. Collection of blood and urine samples was not only helpful in 
triangulating our findings, but could serve as a potential tool to compare with findings from 
elsewhere. All data collection and handling was done by a single researcher thus saving from 
the risk of inter-rater non-reliability. Special training for the use of CIDI instrument was 
taken before field visit. We used fully structured tools with diagnostic capacity and also 
symptom measures that would help to understand the multitude of the same disease 
phenomenon. There were not only selection bias common to multicenter studies but also a 
quick, numerous and effective. This enhanced the external validity of our findings. Moreover, 
we were able to recruit a majority of samples as fully inclusive from several treatment units.  
Internal validity: The study had minimal attrition rates, but it was not free of bias in terms of 
selection and information. In order for our results to be representative to the treatment seekers 
of the whole country, a probability sampling method for treatment units should have been 
applied. Misclassification of „caseness‟ may be more characteristics of psychiatric research in 
general. And patient attribution is a factor often missed to address. Level of stress as 
measured in HSCL-25 could be a function of stress acquired at the particular institution in 
course of treatment. Lack of relevant explanatory variable (often identified by ethnographic 
means) and small sample size may have resulted in confounding. We tried to limit this by 
stratification in age, testing our analytical results by controlling for different 
sociodemographic strata, and by running binary logistic regression analysis, as in paper I, 
since both age and gender are known to be notorious confounders. 
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Assessment validity/reliability: It relates to the appropriateness of technique for collection 
and testing of the samples. Though blood sample collection, serum separation, storage, and 
transfer was done by the researcher using the recommended preservation standards 
(temperature, testing time, etc), issues of standardization of the parameters in analyses was 
difficult to control for. The recording of drinking volume and its operationalized unit 
measures are more arbitrary than standard because of reporting errors and heterogeneity of 
ethanol concentration in locally brewed liquors. Regarding the psychometric tools, we 
believe that previous clinical experience in the same population helped us to interpret the self 
reporting of symptoms, the limitation in this process should be reckoned. Besides, there are 
concerns that CIDI tools may not validly pick the cultural aspects of the depressive and 
anxiety diagnoses among the Nepalese general population (83;112).   
External validity: A robust internal validity is required in order for a study findings to be 
applicable in wider population. As regards paper I, the use of diagnostic tools with fully 
structured questionnaire to reach the diagnosis of induring major depressive episode could 
have balanced the under and over reporting. Alcohol dependence as a diagnosis may not be a 
difficult diagnosis to establish specially in the population of our study. We are claiming the 
validity of our findings also because positive caseness were associated with high number of 
positivity of individual symptoms required for diagnosis. This was elucidated by a medium 
concordance between HSCL-25 depressive symptoms score and MD diagnoses (Pearson‟s 
correlation coefficient= 0.34). We argue that the depressive symptoms count may not 
necessarily reflect the rates of MD diagnoses being made. 
With this, we would like to discuss the generalizability of our findings. Kathmandu as a study 
site is better than nowhere else in Nepal for substance abuse research. This is because the 
indigenous Newar people of Kathmandu are minority, it is the largest concentration area of 
the whole country, and Kathmandu harbors people of all strata of sociodemographics. 
Kathmandu is undoubtedly a preferred site for health care. Since no publicly funded 
treatment is available for alcohol users, economic affordability of patients in elsewhere may 
be comparable to that of people in Kathmandu although threshold for treatment seeking may 
be different. However, our findings in no way represents the comorbidity patterns in general 
population levels. Generalizability to other regions should be made with caution, as both 
patterns of alcohol use, cultural attribution to mental illnesses, threshold for treatment 




Department of Psychiatry at TUTH saw around 60 patients everyday from Sundays to 
Fridays, with a varying number of admissions per working day. There were 10 beds allocated 
for detoxification purposes at the de-addiction ward. Similarly, the rehabilitation centres had 
a capacity of between 10 and 50 clients. Patients were consecutively recruited. Ethical review 
took 38 days for initial review until which patient recruitment was disallowed. The data 
collection portion of the study lasted between 130 days (between Aug 17-Dec 28 ,2010). Data 
entry, data cleaning, data analysis, thesis and first article writing took another 4 months to 
complete. See table below for specific months of the study timeline.  
 
Activity Time Period 
Protocol writing and research planning April-June 2010 
Training May-June 2010 
Pilot testing, ethical clearance July-August 2010 
Recruitment August- December 2010 
Data entry and data cleaning January-February 2011 
Data analysis Febraury-April 2011 
Thesis writing April-May 2011 
Thesis submission  May 2011 
Paper I submission May 2011 
paper II  August-September 2011 
Paper III+  Oct-Dec 2011+ 
Immunological analysis and Paper IV May 2011 
  Table 5. Timeline of the study. Months for papers indicate the months planned for paper 
writing and submission. Blue shaded cells contain time plan for ongoing/planned activities 
which have not been completed. 
2.13 Dissemination of Results 
In the study protocol, we committed to distributing the results of the study in the form of 
thesis work. Many participants wished to receive the reports of blood and urine tests, and thus 
a list of the participants who wished so was prepared. The results will be sent to the 
respective treatment units via registered post, upon permission from the concerned ethical 
review board. An arrangement for contacting the participants was made in co-ordination with 
the host institutions. We have sent a note about this to the ethical review committees which 
granted approval to the study protocol. The reports will be distributed soon after such an 
approval for report distribution. 
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Owing to the richness of collected data, the analyses were done in phases and ongoing. In the 
first phase, correlation between our main dependent variable (major depression comorbid 
with an alcohol-use disorder) with demographic and clinical characteristics were examined. 
We attempted to explore the differences in the two social categories in regard to depressive 
outcome on the background of demographic and clinical explanatory variables. This made the 
core of our first article.  
After the analysis of the data one article was written, coauthored by the supervisor, and 
submitted for publication in the journal „Addiction‟. Coauthoring was done according to the 
Vancouver rules where the supervisor‟s role was inception, formulation, securing of project 
financing, guidance, planning statistical analyses, review, and acceptance to the final draft 
before submission. 
The thesis was submitted to the University of Oslo and the copies are planned to be provided 
to collaborating institutions together with the first article after its publication. The University 
library of Health Sciences in Oslo will retain a copy of the same in electronic version. The 
report will be made available at SERAF‟s website and other pertinent internet pages. 
Publication in the local newspapers is also considered. Results of the study and its 
implication shall be shared with relevant governmental and non-governmental agencies. 
2.13.1 Planned papers 
 Besides the first paper, following themes have been considered for write-up from the 
collected data: 
1. Current psychological distress (HSCL-25) and lifetime major depression (CIDI) among 
AUD patients; are there correlations? 
2. Descriptive study of concomitant nicotene and other substance abuse among treatment 
seekers of AUD in Nepal. 
3. Does adverse life experiences (CIDI PTSD) predict psychiatric comorbidity among AUD 
patients? 
4. Impairment levels of AUD patients who seek treatment- in terms of road traffic accidents, 
social/professional inability to deliver responsibilities, etc relating with severity and patterns 
of alcohol use (CIDI alcohol use module and TLFB) 
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5. Suicidal ideation, plans and attempts on AUD patients who sought treatment at Nepalese 
treatment units. 
5. Usefulness of serum GGT, CDT and EtG in a resource poor setting comparing findings 
from elsewhere. 
6. Does ethnicity modulate the intricate balance of pro-inflammatory and anti-inflammatory 
cytokine levels among comorbidly ill AUD inpatients? Are there differences between 
depressed and non-depressed AUD patients in the levels of the circulatory cytokines? How 
are these levels comparable to the findings from Norway? 
2.14 The Researcher 
The researcher is a licensed medical doctor from Nepal and has had experiences with treating 
the cases of depression, anxiety disorders and alcohol dependence both in inpatient and 
outpatient settings. He got training on the administration of WHO devised composite 
international diagnostic interview (see appendix and psychometrics section). He conducted 
all the interviews and collected the blood and urine samples. He was involved directly and 
solely in the data collection process, except in the laboratory analysis which took place in 
Norway. The processing of biological samples which took place in Nepal was also carried out 
by him, and is mentioned in material section. 
2.15 Supervision and Collaboration 
The supervision for this study was provided by Professor Dr. Jørgen G. Bramness, the 
research director at the Centre for Addiction Research (SERAF), Faculty of Medicine, 
University of Oslo. He provided supervision in the whole process from its inception to 
reviewing the report, in accoutring necessary funding, and forging collaboration with 
laboratories in Norway. His extensive knowledge and experiences in this field of research 
contributed substantially to assure the scientific quality and overall project management for 
this study. He also provided every opportunity to SPN for introducing him to scientific milieu 
in different arenas. 
Dr. Saroj Prasad Ojha, associate Professor at the department of Psychiatry at the Institute of 
Medicine, Tribhuvan University, Kathmandu provided facilitation in local settings as a co-
supervisor. He was responsible for negotiating with the host teaching hospital for recruitment 
of participants.  
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The participating centres provided access to their clients and a private room for data 
collection. The department of Biochemistry at Tribhuvan Univeristy teaching hospital 
granted permission for processing of blood samples and storage of blood and urine samples in 
a laboratory under their premises.  
During data collection, Prof Helge Waal from the Centre for Addiction Research visited the 
field and provided his insightful advice. Training for the administration of CIDI was provided 
by Anne Signe Landheim at the regional competence centre for dual diagnosis in Sanderud, 
Norway. CIDI Questionnaires in Nepali were provided by Mark van Ommeren at WHO, 
Zeneva. Nepali version of AUDIT was obtained from Transcultural Psychosocial 
Organisation Nepal. Fürst Medical Laboratories in Oslo conducted the first series of 
laboratory tests. Support was received from the Toxicological laboratories at the Norwegian 
Public health Institute for initial collection of shipment from Nepal. Regional competence 
centre for double diagnosis (RKDD) in Sanderud hospital (Innlanded hospital trust, Norway) 
took charge of storing the biological specimen until further analyses. Financial support for 
SPN during the data collection and report writing period was received from the Norwegian 
State Educational Loan Fund. The research was funding by internal sources at the Norwegian 
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DSM-IV Diagnostic criteria for Substance Withdrawal Delirium  
A.   Disturbance of consciousness (i.e., reduced clarity of awareness of the environment) with 
reduced ability to focus, sustain, or shift attention. 
B.   A change in cognition (such as memory deficit, disorientation, language disturbance) or 
the development of a perceptual disturbance that is not better accounted for by a preexisting, 
established, or evolving dementia. 
C.   The disturbance develops over a short period of time (usually hours to days) and tends to 
fluctuate during the course of the day. 
D.  There is evidence from the history, physical examination, or laboratory findings the 
symptoms in Criteria A and B developed during, or shortly after, a withdrawal syndrome. 
Note: This diagnosis should be made instead of a diagnosis of Substance Withdrawal only 
when the cognitive symptoms are in excess of those usually associated with the withdrawal 
syndrome and when the symptoms are sufficiently severe to warrant clinical attention. 
DSM-IV Diagnostic Criteria for Alcohol Abuse 
1. A maladaptive pattern of alcohol abuse leading to clinically significant impairment or 
distress, as manifested by one or more of the following, occurring within a 12-month period: 
a)      Recurrent alcohol use resulting in failure to fulfil major role obligations at work, 
school, or home (e.g., repeated absences or poor work performance related to 
substance use; substance-related absences, suspensions or expulsions from school; or 
neglect of children or household). 
b)      Recurrent alcohol use in situations in which it is physically hazardous (e.g., driving 
an automobile or operating a machine). 
c)      Recurrent alcohol-related legal problems (e.g., arrests for alcohol-related disorderly 
conduct). 
d)      Continued alcohol use despite persistent or recurrent social or interpersonal 
problems caused or exacerbated by the effects of the alcohol (e.g., arguments with 
spouse about consequences of intoxication or physical fights). 
2. These symptoms must never have met the criteria for alcohol dependence. 
 
DSM-IV Diagnostic Criteria for Alcohol Dependence 
A maladaptive pattern of alcohol use, leading to clinically significant impairment or distress, 
as manifested by three or more of the following seven criteria, occurring at any time in the 
same 12-month period: 
1.       Tolerance, as defined by either of the following: 
a)      A need for markedly increased amounts of alcohol to achieve intoxication or 
desired effect. 
b)      Markedly diminished effect with continued use of the same amount of alcohol. 
2.       Withdrawal, as defined by either of the following: 
a)      The characteristic withdrawal syndrome for alcohol (refer to DSM-IV for 
further details). 
b)      Alcohol is taken to relieve or avoid withdrawal symptoms. 
3.       Alcohol is often taken in larger amounts or over a longer period than was intended. 




5.       A great deal of time is spent in activities necessary to obtain alcohol, use alcohol or 
recover from its effects. 
6.       Important social, occupational, or recreational activities are given up or reduced 
because of alcohol use. 
7.       Alcohol use is continued despite knowledge of having a persistent or recurrent physical 
or psychological problem that is likely to have been caused or exacerbated by the alcohol 
(e.g., continued drinking despite recognition that an ulcer was made worse by alcohol 
consumption). 
DSM-IV Diagnostic Criteria for Major Depressive Episode 
A. Five (or more) of the following symptoms have been present during the same 2-week 
period and represent a change from previous functioning; at least one of the symptoms is 
either (1) depressed mood or (2) loss of interest or pleasure. 
Note: Do note include symptoms that are clearly due to a general medical condition, or 
mood-incongruent delusions or hallucinations. 
1. depressed mood most of the day, nearly every day, as indicated by either subjective 
report (e.g., feels sad or empty) or observation made by others (e.g., appears 
tearful). Note: In children and adolescents, can be irritable mood. 
2. markedly diminished interest or pleasure in all, or almost all, activities most of the 
day, nearly every day (as indicated by either subjective account or observation made 
by others) 
3. significant weight loss when not dieting or weight gain (e.g., a change of more than 
5% of body weight in a month), or decrease or increase in appetite nearly every 
day. Note: In children, consider failure to make expected weight gains. 
4. insomnia or hypersomnia nearly every day 
5. psychomotor agitation or retardation nearly every day (observable by others, not 
merely subjective feelings of restlessness or being slowed down) 
6. fatigue or loss of energy nearly every day 
7. feelings of worthlessness or excessive or inappropriate guilt (which may be 
delusional) nearly every day (not merely self-reproach or guilt about being sick) 
8. diminished ability to think or concentrate, or indecisiveness, nearly every day (either 
by subjective account or as observed by others) 
9. recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without 
a specific plan, or a suicide attempt or a specific plan for committing suicide 
B. The symptoms do not meet criteria for a Mixed Episode. 
C. The symptoms cause clinically significant distress or impairment in social, occupational, 
or other important areas of functioning. 
D. The symptoms are not due to the direct physiological effects of a substance (e.g., a drug of 
abuse, a medication) or a general medical condition (e.g., hypothyroidism). 
E. The symptoms are not better accounted for by Bereavement, i.e., after the loss of a loved 
one, the symptoms persist for longer than 2 months or are characterized by marked functional 
impairment, morbid preoccupation with worthlessness, suicidal ideation, psychotic 






This consent is applicable to the patients attending …………………………..Hospital/Centre for treatment 
of problems related to alcohol consumption, and willing to participate in the study titled `Prevalence 
and correlates of major depression and anxiety disorders among patients with alcohol-use disorders 
in Nepa l’ 
PART I: Information Sheet 
Introduction 
I am Sudan Prasad Neupane, a Master student at University of Oslo in Norway. I am a doctor by 
background and doing research on alcohol use and common mental illnesses which are very common 
in this country. I am going to give you information and invite you to be part of this research. You do 
not have to decide now whether or not you will participate in the research. Before you decide, you can 
talk to anyone you feel comfortable with about the research.  
There may be some words that you do not understand. Please ask me to stop as we go through the 
information and I will take time to explain.  
Purpose of the research 
Use of alcohol in our country is very common and many people have physical and mental illnesses 
related to this. This research is being conducted to find out how frequently are common mental 
illnesses associated with alcohol use and to find out the relevant socio demographic characteristics of 
the individuals who come to get treatment at this hospital. We want to perform blood tests to better 
understand this relationship.  
Voluntary Participation 
Your participation in this research is entirely voluntary. It is your choice whether to participate or not. 
Whether you choose to participate or not, all the services you receive at this clinic will continue and 
nothing will change. You may change your mind later and stop participating even if you agreed 
earlier. 
Procedures and Protocol 
Taking part in this study, we request you to answer questions I will be asking you regarding your 
health. We will take about 5 millilitres of blood from your arm using a syringe and a needle and we 
will take it only once. The blood sample will be sent to Norway for analysis and all of it will be 
destroyed after the laboratory tests are done. The samples collected will be used to investigate 
cytokine levels as well. But all your identity will be confidential. I will contact you on your address if 
you would like to know the results and if they are important for your treatment.  
 Description of the Process 
During the research you will attend the interview session and give blood sample the same day. We 
will contact you for necessary if you agree upon. The research will last until June 2011. You might be 
asked to participate in follow up research in future if you choose to be contacted.   
Risks/Benefits of participation 
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Except for your time, this study will incur no risks as such in any way. We will not ask you for any 
kinds of payments for the blood tests and will report the results to you if you wish to be or if they are 
important for your treatment. You will be offered snacks during the interview.  
Reimbursements 
A cash payment of Rs. 100 will be made to you for your lost work time if you are coming for 
interview for the research participation. You will not be given any other money or gifts to take part in 
this research.  
Confidentiality 
We will not be sharing the identity of those participating in the research. The information that we 
collect from this research project will be kept confidential. Information about you that will be 
collected during the research will be put away and no-one but the researchers will be able to see it. 
Any information about you will have a number on it instead of your name. Only the researchers will 
know what your number is and we will lock that information up. It will not be shared with or given to 
anyone except my University, and your clinician.  
Right to Refuse or Withdraw 
 You do not have to take part in this research if you do not wish to do so and refusing to participate 
will not affect your treatment at this clinic in any way. You will still have all the benefits that you 
would otherwise have at this clinic. You may stop participating in the research at any time that you 
wish without losing any of your rights as a patient here. Your treatment at this clinic will not be 
affected in any way. 
Who to Contact 
If you have any questions you may ask them now or later, even after the study has started. If you wish 
to ask questions later, you may contact me at the following: Sudan Prasad Neupane, Gundu 01, 
Bhaktpaur, Tel: 00977 1 6616857, Mobile: 00977 9841633319, email: thelonelyplanet@gmail.com  
 
This proposal has been reviewed and approved by the national Research ethics committee in Norway 
and Nepal and the Research ethics committee at this hospital. These committees‟ task it is to make 
sure that research participants are protected from harm.   
 
You can ask me any more questions about any part of the research study, if you wish to. Do you 






PART II: Certificate of Consent 
 
I have read the foregoing information, or it has been read to me. I have had the opportunity to ask questions about it and any 
questions that I have asked have been answered to my satisfaction.  I consent voluntarily to participate as a participant in this 
research. 
Print Name of Participant                                             Chose to be contacted for further research   Yes/No  
   
Signature of Participant ___________________ 
Date ___________________________ Day/month/year  
   
If illiterate 
I have witnessed the accurate reading of the consent form to the potential participant, and the individual has had the 
opportunity to ask questions. I confirm that the individual has given consent freely.  
 
Print name of witness_____________________                                  Thumb print of participant 
Signature of witness ______________________ 
Date ________________________ 




Statement by the researcher/person taking consent 
I have accurately read out the information sheet to the potential participant, and to the best of my ability made sure that the 
participant understands that the following will be done:  1. Interview 
   2. Blood sample collection 
I confirm that the participant was given an opportunity to ask questions about the study, and all the questions asked by the 
participant have been answered correctly and to the best of my ability. I confirm that the individual has not been coerced into 
giving consent, and the consent has been given freely and voluntarily.  
   
 A copy of this ICF has been provided to the participant. 
 
Print Name of Researcher/person taking the consent________________________    
Signature of Researcher /person taking the consent__________________________ 
Date ___________________________  
                 Day/month/year 
(Adapted from WHO format for Informed Consent form for Clinical research, a Nepali translation for the same will 






                                              भन्जुयीनाभा पायभ                                                                                            
मस भन्जुयीनाभा पायभ त्रि.त्रफ शिऺण अस्ऩतार, काठभाडँ /.........................................भा जाड यक्सस सेवनको सभस्माका 
कायण उऩचायका राशग आउन ुबएको त्रफयाभीको राशग हो जो शनम्न अनुसन्धानभा िहबागी  हुन शमऺुक हुनुहुन्छ।  `           
 alcohol-use disorders   ’ 
मस पायभभा दइु बाग छन:्  क, जानकायी पायभ य    ख, भन्जुयीनाभाको प्रभाणऩि 
 
बाग क. जानकायी पायभ  
ऩरयचम: भेयो नाभ सुदन प्रसाद न्मौऩाने हो, ओश्लो त्रफश्मोत्रफधामारमभा आध्ममनयत छु, ऩेसारे डासटय हु य हार जाडयससीको 
प्रमोग य भानाशिक योग सम्फन्धभा अनुसन्धानयत छु । मी सभस्मा हाम्रो देिभा शनसकै गक्म्बय रुऩभा यहेका छन। भ 
तऩाईंराई आफस्मक जानकायी दददै मस अनुसन्धानभा िहबागी हुन अनुयोध गददछु। मस्को राशग तऩाईंरे सभम शरएय त्रफचाय 
गनद वा अरु कस ैसॉग ऩयाभिद शरन ससनुहुनेछ। कुनै कुया फुझ्न अप्ठयो बएभा सोध्न ुहोरा। 
अनुसन्धानको उदेश्म :  हाम्रो देिभा जाडयससी को प्रमोग ब्मप्त यहेकोछ य  मस्को कयणरे त्रफबन्न िायीरयक य भानशिक सभस्माहरु 
हुनेगयेका छन। जाडयससीको प्रमोग सॉग भानशिक योगको सम्फन्ध कस्तो यहेकोछ य कुन दकशसभका साभाक्जक य ब्मत्रिगत 
ऩरयफेस सॉग शम दफुै योगको सम्फन्ध छ बन्ने कुया ऩत्ता रगाउनु नै मो अनुसन्धानको प्रभुख उदेश्म यहेकोछ। उऩचायको राशग 
आउन ुबएको ब्मत्रिहरुको यि ऩरयऺण सभेत गयेय मो अनुसन्धान गरयनेछ। 
सोक्छछक िहबागीता: तऩाईंको िहबागीता ऩूणद रुऩभा सोक्छछक यहनेछ। तऩाइरे मो अनसुन्धानभा बाग शरए वा 
नशरए,तऩाइरे मस अस्ऩतारफाट उऩरब्ध गयाईने सेवाभा कुनै असय ऩनेछैन। तऩाईरे सहबाशगता फाये शनणदम कुनै ऩशन फेरा 
दपताद शरन ससनु हुनेछ। 
प्रदिमा : मस अनुसन्धानभा बाग शरदा तऩाईराई व्मत्रिगत स्वास््म सम्फन्धी प्रश्नहरु सोशधनेछ. केवर एक ऩटक तऩैको 
ऩाखुया फाट ५ शभ.शर. यगत य ३ शभशरशरटय त्रऩसाऩ जाचको राशग नफ ेऩठाईनेछ। य उल्रेक्खत जाच सकेऩशछ उि यगत ऩूणद 
रुऩरे नस्ट गरयनेछ। एस ऩशछ भैरे गन े आध्ममनभा ऩशन उि येऩोटको प्रमोग गरयनेछ। तय तऩाईको ऩरयचम गोप्म 
यक्खनेछ। मदद तऩाईराई शमच्छा छ बने य उऩचायको दृत्रिरे भहत्तोऩूणद छ बने रयऩोटद सदहत सम्ऩकद  गरयनेछ।   
प्रदिमा त्रववयण : मस सन्दबदभा तऩाईको अन्तयफाताद य यि/ त्रऩसाऩ सॊकरन एकै ददन गरयनेछ। आवश्मक बेटघाटका राशग 
तऩाईको अनुभशतभा सम्ऩकद  गरयनेछ। मस अध्ममन ई.सॊ २०११ को जुन भदहना सम्भ जारय यहनेछ। मस ऩशछको अध्ममनभा 
शमऺुक व्मत्रिराई सम्ऩकद  गनद सदकनेछ ।  
सहबाशगताका पाइदा/फेपाइदा: तऩाईको सभम फाहेक मस अध्ममनका कायण कुनै दकशसभको फेपाइदा हुनेछैन। केदह 
ऩरयऺणका रयऩोटदहरु तऩाईको उऩचायको दृत्रिरे पाइदाजनक हुनेछन। तऩाइराई यि ऩरयऺणका राशग बनेय वा अन्म कुन ै
कायणरे कुन ै दकशसभको सुल्क शरईनेछैन।  अन्तयफातादको िभभा साभान्म नास्ताको व्मवस्था गरयनेछ। ऩुयाना 
घटनािभहरुको स्भयणरे तऩाईराई केदह अप््मायो भहिसु हुन ससछ। त्मस अफस्थाभा तऩाईराई सहज अनुबफ गनद 
सघाईनेछ। कृऩमा आफ्ना सभस्मा वा क्जऻािा बएभा अन्तयफातादको अक्न्तभभा सोध्नुहोरा। 
खचदको व्मवस्था:  मदद अन्तफादतादको शनक्म्त घयफाट आउनुबाको छ बने तऩैको अन्तफादतादको शनक्म्त खशचदनु बएको सभमका 
राशग रू. १०० य गाडी बाडाको राशग अशधकतभ रु. २५० खचद उऩरभ्द गरयनेछ। अन्म कुनै दकशसभको सुत्रफधा उऩरब्ध 
गरयनेछैन। 
गोऩशनमता: मस अध्ममनका सहबागीको ऩरयचम खरुािा गरयनेछैन। सम्ऩूणद त्रववयण गोऩशनम ढॊगरे याक्खनेछ। तऩाईको 
व्मत्रिगत त्रववयण य अन्तयफाताद त्रववयण य यि/ त्रऩसाऩ ऩयीऺणको रयऩोटद एक सॊकेत नॊफय फाट सम्फक्न्धत गयाईनेछ। सो 
सॊकेत नॊ को सम्फन्ध भराई भाि थाह हुनेछ। उऩोयोि त्रववयण ओश्लो त्रफस्वोत्रवद्यारम, वा तऩाईको उऩचायभा सॊरग्न 
शचदकत्िक सॊग भाि आदानप्रदान गरयनेछ।  
प्रशतवेदन आदानप्रदान : मस अध्ममन फाट प्राप्त हुने नशतजा तऩाईको शचदकत्सक भापद त अस्ऩतारभा येकडद गरयईने छ। 
बत्रफश्मभा तऩाईको उऩचायभा उि नशतजाको भहत्व फाये तऩाईको उऩचायभा सॊरग्न शचदकत्िक सॊग छरपर गरयनेछ। 
व्मत्रिगत त्रववयण फाहेकका फैऻाशनक प्रमोजनरे भहत्तोऩूणद त्रववयण त्रवशबन्न भाध्मभफाट आदानप्रदान गरयनेछ। मस फाट 
शमऺुक व्मत्रि वा सभुहरे मस अनुसन्धानको अध्ममन गनद ससनेछन। 
नकानद सदकने तऩाईको अशधकाय : तऩाईराई एस अध्ममनभा शमच्छा नबएको खण्डभा सहबागी नहुने ऩूणद अशधकाय छ। 
तऩाईको मस शनणदमरे अस्ऩतारफाट उऩरब्ध गयाईने कुन ै ऩशन सुत्रफधाभा कुन ै दकशसभको असय ऩनेछैन। तऩाईको मस्तो 





सम्ऩकद  ठेगाना :  
तऩाईराई कुन ैदकशसभको क्जऻािा बएभा अदहरे वा ऩशछ ऩशन सोध्न ससनुहुनेछ। ऩशछ सम्ऩकद को राशग शनम्न ठेगाना प्रमोग 
गनद ससनु हुनेछ।  
सुदन प्रसाद न्मौऩाने, ऩो फसस १३१२३ काठभाडं .पोन नॊ. ९८४१६३३३१९  
वा Neupane, Sudan Prasad. Norwegian Centre for Addiction Research (SERAF) Kirkeveien 166, University of Oslo, 0450 
Oslo. NORWAY Tel:0047 98861090 
नोट: मस अनुसन्धान नफकेो यात्रिम इशथकर फोडद अन्तगदतको कशभटी य नेऩार स्वास््म अनुसन्धान ऩरयifb फाट स्वीकृती 
प्राप्त छ। अफ तऩाईरे मस अनुसन्धान सम्फक्न्ध कुन ैक्जऻािा याख्न ससनुहुन्छ। कुनै प्रश्न वा क्जऻािा छ?   
 
बाग २. भन्जुयीनाभाको प्रभाणऩि  
भैरे उऩयोि जानकायी ऩाए, वा सो जानकायी भेयो राशग ऩढेय सनुाइएको छ। मसको फायेको थऩ जानकायी शरने अवसय 
उऩरब्ध गरयमो य क्जऻािाको सन्तोषजनक जफाप ऩाएॉ। भ सोक्छछक रुऩभा मस अध्ममनभा सहबागी हुन भन्जुय छु।                
                                  थऩ अध्ममनका राशग सम्ऩकद  गरयन चाहन्छु/चाहददन (ठीक रगाउने) 
सहबागीको ऩुया नाभ, थय : 
सहबागीको ठेगाना: 
 पोन नॊ : 
सहबागीको हस्ताऺय : 
शभशत:  
         
  
 
शनयऺयको राशग                                                                                                             
भैरे नीज सहबागीराई आवश्मक जानकायी ददने भन्जुयीनाभा ऩदढएको सनेु य नीज सहबागी राई प्रश्न गनद भौका ददएको 
सभेत हेये। मस अध्ममनको राशग साऺी फस्दै छु य िहबागीरे ऩूणदरुऩरे सोक्छछक भन्जुयीनाभा ददएको ऩसका गददछु।  
  साऺीको ऩुया नाभ, थय :     
साऺीको हस्ताऺय :                                 
शभशत :       
अनुसन्धानकताद वा भन्जुयीनाभा बयाउने व्मत्रिको फिब्म:  
भैरे ऩूणदरूऩभा जानकायी पायभ ऩढेय सहबागीराई सनुाए अशन भेयो ऺभतारे बएसम्भ उहाराई शनम्न कुयाहरु गरयने फुझाए।  
क. अन्तयफाताद  
ख. यगत सॊकरन  
अनुसन्धानको सम्फन्धभा सहबागीराई प्रश्न गने भौका ददईएको य भेयो ऺभतारे भ्माएसम्भ फुझ्ने गरय जफाप ददएको कुया 
प्रभाक्णत गनद चाहन्छु। नीजराई सोका राशग कुनै दकशसभ को दफाफ ददएको छैन य भन्जुयीनाभा ऩूणद रूऩरे स्वोतन्ि य 
सोक्छछक बएको प्रभाक्णत गददछु।  
मो भन्जुयीनाभको एक प्रशत सहबागीराई उऩरब्ध गयाईएको छ.  
अनुसन्धानकताद वा भन्जुयीनाभा बयाउने व्मत्रिको नाभ, थय:  
अनुसन्धानकताद वा भन्जुयीनाभा बयाउने व्मत्रिको हस्ताऺय: 
शभशत:  





















SECTION A: Demography  
INTERVIEWER‟S NAME _____________________                    INT CODE ___/___/___ 
 
ID CODE ___/___/___/___/___/___/___                      LANGUAGE OF INTERVIEW____ 
TIME BEGAN  ____ TIME ENDED___                     DATE DAY___/___MO___/___YR___/___ 
 
A1. SEX AS OBSERVED (cross).           
    MALE 1..........   
    FEMALE 2.................... 
 
A2.  How old are you?  







    (ASK DATE OF BIRTH WHERE APPROPRIATE) DAY___/___ MO___/___ YR___/___ 
 
A3. Where have you been living in the past 5 yrs? 
 _________Your place of origin?_________(Urban1/Rural 2)__________ 
 
A4. What ethnic background are do you belong to? (Don‟t ask when obvious)  
Brahmin 1__Chhetri 2___Newar 3__Tamang 4__Rai/Limbu/Gurung 5__Sherpa 6__Magar 
8__Madhesi9__ 
 STRATIFY: TAGADHARI A1___________/MATWALI A2 ______ 
 
A5. Are you presently married, or are you widowed, separated, divorced, or have you never been married? 
                   Never married.....1 
               Married and/or cohabiting............2 
 Divorced or living separately........3 
Widowed or other…..4  
 
A6.  How many children have you had, not counting who are yours by adoption or who were born dead?   
__ 
 
A7. What is your current occupation?  
Unemployed 1__gharelu industry 2__ farmer 3__ service (private or government firms)4__own 
business     5__ (Mention if others)___ 
A8. How many years of schooling have you completed? 
None 1__, some school (up to 7 years or attended adult education)2__Secondary (8-12years)3__          
University 4__ 
           Mention if still at school_____________ 
 
A9. Do you usually speak Nepali at home?  
Yes__ No__ . If No, Mother tongue_______ 
 
A10. How do you find yourself socially supported morally and logistically when you are in need of some 
kind? 
                None 1___ 
   Some 2___ 
   Adequate 3___ 







Patient Satisfaction And General Health Questionnaire 
1. In general, how satisfied are you with the treatment you have been offered which you 
sought for your drinking problem ? 
Very dissatisfied……………….1 
Dissatisfied……………………..2 




2. Have you ever suffered from any kind of illness for longer than three months? (If yes, 
mention)   
Yes/ No       Particular:  
 
3. Have you ever had any sorts of surgeries under anesthesia? (If yes, mention)   
Yes/ No       Particular:  
 
4.  Are you currently on any medications? (If yes, mention)   
         Yes/ No       Particular:  
 
5. Do you smoke cigarettes? Chew tobacco or smoke hukka? (If yes, mention)  If No, skip 
Yes/ No       Particular(type, quantity and frequency/day/duration):  
 
6. Did you use to smoke cigarettes? Chew tobacco or smoke hukka? (If yes, mention)   
Yes/ No       Particular(type, quantity and frequency/day/duration): 
 
7. Problem drinking in family:   (Yes/No)        (relation)___________  




X1.   DID R ANSWER ALL APPLICABLE QUESTIONS?       
X2 DID R REFUSE TO ANSWER ANY QUESTION(S)?  
A. HOW MANY QUESTIONS DID R REFUSE? ___/___/___ 
B. WHICH QUESTIONS DID R REFUSE? 
X3 DID R UNDERSTAND ALL QUESTION(S)? 
A. WHICH QUESTIONS DIDN‟T R UNDERSTAND? 
X4 IS R A MEMBER OF AN ETHNIC MINORITY?  
A. IS R‟S ETHNIC GROUP OF HIGH OR LOW STATUS? 
X5 WAS THE INTERVIEW A BREAK-OFF?  
A. WHAT WAS THE REASON FOR THE BREAK-OFF? 
B. WHAT WAS THE LAST QUESTION ANSWERED BY R? 
X6 WHAT WAS R‟S RESPONSE TO POSSIBLE FUTURE INTERVIEW?  
EAGER .........................1 RECEPTIVE.........2 NO REACTION.....3 RELUCTANT................4 
REFUSED..........5 
X7 WAS THE INTERVIEW GIVEN IN MORE THAN ONE SESSION? 
A. AFTER HOW LONG WAS THE INTERVIEW INTERRUPTED? HRS _____ MINS 
_____/_____ 
B. AFTER WHAT QUESTION? Q. ___/___/___ 
X9 INTERVIEWER‟S DESCRIPTION OF RESPONDENT AND INTERVIEW: 
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 I.  Questions for Anxiety Not at all 
-x'b} ePg_ 








-Psbd} w]/} ef]_ 
!= (Suddenly scared for no reason) 
ljgfsf/0f PSsf;L 8/ nfUg] eof] ls ePg<slQsf] eof] < 
1 2 3 4 
@= (Feeling fearful)  
TolQs} cf \˚gf] dg 8/fPsf] ;f]rfO cfof] ls cfPg < slQsf] cfof] < 
1 2 3 4 
#= (Faintness, dizziness or weakness)  
rSs/ nfUg], efpGg x'g] jf sdhf]/L dx;'; x'g] eof] ls ePg < 
slQsf] eof] < 
1 2 3 4 
$= (Nervousness of shakiness inside)  
dg cflQg],ge{; x'g] eof] ls ePg < slQsf] eof] < 
1 2 3 4 
%= (Heart pounding or racing)  
d'6' xlNng] -l56f] l56f] 9's9's ug]{_ ;d:of eof] ls ePg < slQsf] 
eof] < 
1 2 3 4 
^= (Trembling)  
xftv'§f jf k'/} z/L/ sfDg] eof] ls ePg < slQsf] eof] < 
1 2 3 4 
&=  (Feeling tense of keyed up)  
6]G;\ jf tgfju|:t ePsf] cg'ej eof] ls ePg < slQsf] eof] < 
1 2 3 4 
*= (Headaches)  
6fpsf] b'Vof] ls b'v]g< slQsf] b'Vof] < 
1 2 3 4 
(= (Spells of terror or panic)  
8/n]  Psbd} / ‰jf§} cflQg] eof] ls ePg < slQsf] eof] < 
1 2 3 4 
!)= (Feeling restless and can't sit still)  
r'krfk nfu]/ zfGt;+u a:g g;Sg] u/L 56\k6L eof] ls ePg < 
slQsf] eof] < 
1 2 3 4 
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 II.  Questions for Depression     
 




Quite a bit 
-cs;/ ef]_ 
Extremely 
-Psbd} w]/} ef]_ 
!= (Feeling low in energy, slowed down)  
sdhf]/L ePsf] jf zlSt gePsf] h:tf] cg'ej eof] ls ePg <o:tf] 
slQsf] eof] < 
1 2 3 4 
@= (Blaming yourself for things) 
h] sfd lau|] klg cf˚ \g} ulNtn] lau|]sf] eG7fGg' eof] ls ePg < o:tf] 
slQsf] eof] < 
1 2 3 4 
#= (Crying easily)  
hlta]nf klg ;lhn} l;t ?g dg nfUg] eof] ls ePg < o:tf] slQsf] 
eof] < 
1 2 3 4 
$= (Loss of sexual interest or pleasure)  
>Ldfg\÷>LdtL;“u of}g ;Dks{df /dfOnf] gx'g] eof] ls ePg < o:tf] 
slQsf] eof] < 
1 2 3 4 
%= (Poor appetite)  
s]xL vfg dg gnfUg] eof] ls ePg < o:tf] slQsf] eof] < 
1 2 3 4 
^= (Difficulty falling asleep, staying asleep)  
lgbfpg ufx|f] x'g] jf lgGb|fdf la+pl´/xg] eof] ls ePg < o:tf] slQsf] 
eof] < 
1 2 3 4 
&= (Feeling helpless about the future)  
ca d s]xL klg ug{ ;lSbg, ca d]/f] xfnt s] x'g]] xf]nf eGg] ;f]rfO 
cfof] ls cfPg< o:tf] ;f]rfO slQsf] cfof]< 
1 2 3 4 
*= (Feeling blue)  
dg pbf; jf lvGg x'g] eof] ls ePg < o:tf] slQsf] eof] < 
1 2 3 4 
(= (Feeling lonely)  
dx;'; slQsf] ug{'eof] < 
1 2 3 4 
!)= (Thoughts of ending your life)  
cfTdxTof ug]{, d?“ d?“ nfUg] ;f]rfO cfof] ls cfPg < o:tf] ;f]rfO 
slQsf] cfof] < 
1 2 3 4 
!!= (Feeling of being trapped or caught)  
s]xL s'/fdf cfkm' ˚;]sf] h:tf] ;f]rfO cfof] ls cfPg < o:tf] ;f]rfO 
slQsf] cfof] < 
1 2 3 4 
!@= (Worrying too much about things)  
h'g;'s} sfds'/fsf] jf/]df klg Hofbf ;'tf{ nfUg] eof] ls ePg < o:tf] 
slQsf] eof] < 
1 2 3 4 
!#= (Feeling no interest in things)  
sfd s'/f s]xL ug}{ dg gnfUg] eof] ls ePg o:tf] slQsf] eof] < 
1 2 3 4 
!$= (Feeling everything is an effort)  
s'g} klg sfdsfh ubf ldlxg]t ug{' k/]sf] jf ufx|f] ePsf] cg'ej eof] 
ls ePg < o:tf] slQsf] eof] < 
1 2 3 4 
!%= (Feeling of worthlessness) 
cfkm"n] cf˚}+nfO{ sfd gnfUg], a]sf/sf] dfG5] 7fGg'eof] ls  ePg < 
o:tf] slQsf] 7fGg'eof]< 




                                                          
4











Timeline Followback sample calendar (30 days)5 
   
                                                          
5
 Note that this is a sample monthly calendar provided for reference to the participant. Responses were 
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6 Please note that the structure and length of the article is based on the requirement of 
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Introduction Nepal is an ambivalent society in terms of alcohol use: alcohol consumption is 
frowned upon among traditionally ruling upper caste people whereas its use is socially 
accepted among certain lower caste people. We hypothesized that presence of social taboo 
leads to higher rates of depression among consumers of alcohol and that the explanations of 
comorbid depression across the two strata could be different. Aims  1) To investigate if 
belonging to the tabooed social stratum led to higher rates of concomitant major depression. 
2) To correlate sociodemographic and clinical factors with the presence of major depression 
in the two social strata. Methods A cross-sectional survey was carried out among 
consecutively admitted 188 Alcohol-use disorder (AUD) patients in multiple residential 
alcohol treatment units in Kathmandu during the period July- December, 2010. We recorded 
socio-demographic data and administered the alcohol use and depression modules of WHO 
Composite International Diagnostic Interview (CIDI) 2.1, and the Alcohol-use disorder 
Identification Test (AUDIT). Results Depressed AUD patients compared to non-depressed 
AUD patients had significantly more severe alcohol problems and were less likely to be 
cohabitating with a partner. Lifetime and 12-month prevalence of major depressive episodes 
among the alcohol abuser/dependent patients were found to be 45% and 36% respectively, 
with marginally higher rates of major depression in the non-tabooed group. Lacking a stable 
employment, having experienced alcohol-induced blackout, and longer abstention were 
positively associated with major depression in the non-tabooed group. In case of the tabooed 
group, parental problem drinking appeared to be the single most important independent 
correlate (OR=7.7, 95% CI= 2.6-22.3) of comorbid MD. Conclusions Major depression is 
common among patients with alcohol-use disorders in Nepal. Among treatment seekers, 
social taboo on alcohol use seems to have insignificant effect on rates of comorbidity. 
However, lack of stable source of income and alcohol problem severity in case of the non-
tabooed class and familial predisposition in case of the tabooed class may indicate potential 
risk factors for depressive comorbidity. 
Keywords:  Nepal, alcohol, depression, comorbidity, taboo.  




1. Introduction  
Unipolar depressive disorders and alcohol-use disorders (AUDs) constitute the leading causes 
of years lost due to disability worldwide, contributing 6% to the global burden of diseases 
(1). Low- and middle-income countries bear a majority of this burden (2-4). Meanwhile, a 
number of epidemiological surveys (5-8) and clinical studies (9-11) have quite well 
substantiated the frequent comorbidity between AUDs, particularly alcohol dependence, and 
major depression (MD). Approximately one-third of the patients with AUDs, suffer from 
concurrent MD (12), and more depressed than non-depressed AUD patients seek treatment 
(13). Co-occurring depression among AUD patients not only impairs neuropsychological 
functioning (14) but also predicts relapse to alcohol use (15) and increased risk for suicidal 
behaviour (16). 
Several sociodemographic and clinical traits may play a moderating role in the comorbidity 
between AUD and MD. Alcohol abuse and dependence are more prevalent among males. In 
tandem with gender paradigm of MD in population level, depressive symptoms following 
AUD is more common among females (17-19), but neither depression nor problem drinking 
is a province of either gender alone. Older age (17), early onset of alcohol abuse (20;21), 
white race (17;22), and low socioeconomic status (23) are often implicated as risk factors for 
major depression among patients with AUDs. Furthermore, a number of randomized 
controlled trials involving cohorts receiving acamprosate treatment identified younger age, 
unemployment, single living and episodic drinking as vignettes of depressed alcohol-
dependent patients (24). Another notion attributes depressive comorbidity to the pattern of 
alcohol consumption and severity of problems caused by harmful drinking. Following 
Cloninger‟s proposed typologies of alcoholism (25), a number of studies have investigated 
the children of problem drinkers suggesting that parental problem drinking relates both to 
AUDs and depressive mood in the off springs (26-28). The applicability of these findings 
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need to be corroborated in non-Western settings. A meta-analysis of findings from 74 studies, 
mostly from clinical venues, concluded that AUD patients belonging to racial minority 
generally report lower levels of depression than do their Caucasian counterparts (17). The 
generalizability of these findings are, however, limited because the disparity in rates of 
comorbidity could be an artifact produced by differential treatment seeking in natives and 
non-native people (29). Most of the literature by virtue of their research settings list Asian 
population as a minority group, or often as „others‟ thus leading to little inferable details. 
Nepal is a low-income level secular republic lying between India and China. Over 80% of its 
29 million inhabitants follow Hinduism (30), having a multifaceted construct of caste system. 
Caste determines an individual's behaviour, obligations and expectations in the society (31), 
also those relating to alcohol usage. An archaic civil code in 1854 classified the entire 
population into two distinct groups: the „Tagadhari‟ and the „Matwali‟ community. The 
higher castes, viz. Brahmins (the priests and teachers), Kshetriyas and Thakuris (the warriors 
and rulers) constitute the Tagadharis who wear holy cord around their body and among whom 
alcohol use is normatively restricted. On the contrary, consumption of alcoholic drinks is 
banal among the Baishyas (traders, farmers, artisans) and lower castes (labourers) that 
constitute the Matwalis (literally meaning alcohol users). This largely ambivalent society has 
grown to incorporate oriental drinking culture backed by domestic brewing and widespread 
consumption of industrially brewed liquors. Both depression and alcohol dependence are 
associated with considerable shame and stigma in Nepal; alcohol use is specifically tabooed 
among the Tagadharis. Compared with low caste people, high caste people show higher 
abstinence rates (85% vs. 40%, 12-month) (32), but significantly lower depression rates (33). 
Albeit limited, studies indicate that both AUDs and MD are highly prevalent among Nepalese 
populations (33-36).  
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Two studies on Nepalese AUD patients varied in their results between 17% and 94% on 
comorbid MD (37;38), thus necessitating further investigation. Of particular concern is the 
alarmingly high proportion of younger population whose drinking career starts even before 
adolescence (32). Few hospitals run detoxification services to substance dependent 
individuals and an increasing number of 12-step based rehabilitation centres are operating in 
towns. Too little is known about the patient characteristics and affective comorbidity among 
treatment receivers at these centres. Enduring social taboo on alcohol use germane to most 
oriental cultures may have bearing in the depressive psychopathology. Conversely, such 
taboo may alter the threshold of self medicating behavior. In the present study of treatment 
receiving alcohol-use disorders patients, we aimed to estimate the prevalence of major 
depression and investigate if belonging to the tabooed stratum led to increased rates of major 
depression and whether different factors were related to the presence of major depression in 





2. Materials and methods  
2.1 Sample and settings 
A total of 221 individuals 14 years of age and above who were consecutively admitted to the 
detoxification unit of Tribhuvan University Teaching Hospital and seven conveniently 
selected drug/alcohol rehabilitation units in Kathmandu and Lalitpur districts of Nepal were 
considered for participation in this study. Exclusion criteria included: (1) current intoxication 
or ongoing complicated withdrawal; (2) disorientation; and (3) ongoing psychotic symptoms. 
In all, 11 refused to participate, five dropped out, and six were excluded. Another 11 (5.5%) 
of the interviewed individuals did not meet the DSM-IV diagnostic criteria either of alcohol 
abuse or alcohol dependence giving a sample of 188 (85%) patients with an AUD who hailed 
from 44 out of 75 districts of Nepal. Interviews were conducted during August- December 
2010. 
A team of psychiatrists and clinical psychologists provided benzodiazepine based 
detoxification, followed by counseling services during a two-week long stay at the hospital. 
The remaining seven institutions were non-governmental rehabilitation units and comprised 
of 12-step based therapeutic communities. Choice of centre was voluntary and treatment was 
based on out-of-pocket expenditure. Patients developing delirium tremens more commonly 
presented to the hospital. 
2.2 Instruments and Assessment 
Participants completed questionnaires that assessed characteristics including gender, age, 
urbanity of origin and current residence, marital status (never married, married and 
cohabitating, divorced or living separately or widowed), family type (nuclear, joint or 
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extended), education (illiterate, seven years or lower, 8-12 years, or higher), employment 
status (unemployed, student, farmer/domestic work, job holder, or driver/labourer/foreign 
employment) and personal annual income levels (below 60,000, 60,000-100,000, above 
100,000 Nepalese Rupees). Participants self-identified belonging to either Tagadhari or 
Matwali community, and reported their perceived adequacy of social support system. They 
were also asked if any of their parents were known to have had problem drinking in their 
lifetimes. 
The main variables were alcohol abuse, alcohol dependence, and major depressive episodes 
(as dependent variable), all of which were assessed by using the World Health Organization 
Composite International Diagnostic Interview (CIDI) (39). CIDI is a fully structured 
comprehensive interview compatible with the definitions and criteria of Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) (40). The depression and alcohol use 
modules used in this study have shown acceptable reliability and validity in a number of 
studies across a wide range of cultures (41). Nepali version of CIDI (Version 2.1) used in this 
study was previously translated by following standard procedures and administered to Nepali 
speakers (42). Regarding the depression module, both lifetime and 12 month responses were 
recorded. In order to limit possible underreporting, screening symptoms of low mood and 
anhedonia were inquired first without a time string, unlike in the official CIDI which requires 
that the individual have experienced either of these two symptoms more often than not for at 
least two consecutive weeks. MD is referred here to 12-month major depressive episodes as 
measured by CIDI unless otherwise specified. 
We also used the World Health Organization Alcohol-use disorder Identification Test 
(AUDIT) which screens an individual with three questions about hazardous alcohol use, three 
about dependence symptoms and four about harmful alcohol use (43). This tool has enjoyed 
widespread use in clinical and research settings, including demonstrated psychometric 
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properties in a similar setup (44). The two variables regarding consumption of alcoholic 
beverage as the first thing in the morning (eye-opener) and periods of anterograde amnesia 
(alcohol-induced blackouts) as lifetime experiences were constructed from responses to 
AUDIT.  
Despite the possibility of a large variation in the concentration of locally brewed liquors, one 
small bar served glass (roughly 0.2L) of Rakshi (distilled local drink) which is a common 
volume measure in Nepal, was considered 2 standard units of alcohol. Similarly, 1 mana 
(approximately 0.55L) of Jand (domestically fermented drink) was considered equivalent to 3 
units.  
2.3 Procedure and ethics 
Owing to high rates of illiteracy, all questionnaires were paper-and-pencil versions in Nepali 
language and administered by the first author, who also received training to use CIDI. In 
order to limit over-reporting of withdrawal features as axis I symptoms the questionnaires 
were administered no less than 10 days since last drink. All potential candidates available 
during the study period were successfully approached in all but three of the centres in which 
case available patients were recruited in descending order of their recency of last alcohol 
intake. A written informed consent, or in case of illiterate thumb prints of the participant and 
a signature of a witness, was obtained before interviewing in private cells. The study protocol 
received review and approval from the Regional Committee for Medical Research Ethics of 
Norway and from the National Health Research Council of Nepal. 
2.4 Statistical Analyses 
Age was dichotomized at the samples‟ median age. For ease of subgroup analyses, we 
dichotomized the sociodemographic measures according to our pre-understanding of the 
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setting and earlier studies. Group differences were examined using either Pearson‟s χ2 test for 
categorical variables, a Student‟s t-test for continuous variables with a normal distribution or 
a Mann-Whitney U-test for variables not conferring a normal distribution. Binary logistic 
regression analyses (method: Enter) were performed to assess the relation of 
sociodemographic and clinical variables on comorbidity. Predictive ability of variables was 
tested by fitting the variables that showed significant group differences into logistic 
regression models. A p value of < 0.05 was considered significant. All analyses were 
performed using the Predictive Analytics SoftWare (PASW) Statistics version 18.0 (SPSS 





3.1 Sample characteristics and prevalence  
Of the 188 participants meeting criteria for an AUD, 24 (13%) were non-dependent alcohol 
abusers. The median AUDIT score was 30.0 (SD= 8.6) with 150 (82%) AUD patients scoring 
above 20, the cutoff value set by WHO as likely alcohol dependents. A half of the sample, 97 
(52%) were based outside the Kathmandu valley; 18 (including 10 Bhutanese refugee 
women) were foreign born. Nine were repatriates. Almost 90% were males and less than 15% 
were hospital attendees. The age of respondents ranged between 14 and 64 years with the 
mean of 35.3 (SD=10.1) years. In all, 16 were illiterate, 30 were unemployed, 62 had below 
average income levels, and 54 reported of not receiving adequate social support. A majority 
of the sample (N=107; 57%) self identified as belonging to the social class that has taboo on 
alcohol use (Tagadhari). Locally brewed Raksi was the most preferred drink (47%) followed 
by sealed spirits (43%). The mean career of habitual drinking was 16.8 years (SD 9.8). 
Nearly three fourths of the sample admitted of drinking 4 or more days per week. About 75% 
had used alcohol as eye-opener sometime in their drinking career, and 60% had experienced 
alcohol-induced blackouts. 
Eighty-five (45%) of the participants met DSM-IV criteria for lifetime major depression, and 
18 (21%) of them were currently in remission. Over a third 67(36%) of all AUDs patients 
were sufferers of at least one major depressive episode in the preceding 12-month period.  
3.2 Profile of depressed and non-depressed AUD patients 
As shown in table 1, AUD patients below 36 years of age were more likely than their older 
counterparts to have a comorbid major depression. MD was significantly less common 
among married patients than never married, separated or widowed patients; significantly 
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more depressed AUD patients were living in non-nuclear family setups. Almost one in eight 
(12%) depressed AUD patients either had a broken family or was living alone. Those born 
and living in urban areas were more depressed than rural residents. Self reported levels of 
education, income and adequacy of social support did not vary greatly between depressed and 
non-depressed individuals. Non-depressed AUD patients had a more stable employment like 
white collar jobs or were running own businesses. 
Clinical signs of severity of alcohol-use disorders, rather than the drinking pattern, displayed 
stronger association with having experienced a major depression (table 1). AUD patients who 
used eye-openers, had experienced alcohol-induced blackouts, and reduced their priority of 
important activities were more likely to having experienced major depression. Additionally, 
more depressed than non-depressed AUD cases had faced drinking related police 
apprehensions. Patients drinking 2-3 days a week were least likely to be depressed. Of the 
considered 11 alcohol withdrawal signs, median number of withdrawal signs reported was 7 
(SD=3.7) with the depressed group reporting significantly numerous signs compared to the 
non-depressed group. Over a third or 69 (37%) of the AUD patients reported parental, only 
three were maternal only, lifetime problem drinking. Parental problem drinking was 
significantly associated with MD. 
Patients who admitted to early onset habitual drinking were significantly more likely than the 
late starters to have MD. Notably, average AUDIT scores did not vary markedly between 
depressed and non-depressed groups. Just over 70% of the females hailed from Matwali 
community and they scored lower in AUDIT as compared to their male counterparts. The 
difference observed in eye opening as background variables for depressive outcome were 




3.3 Social Taboo and MD 
Of the sample, 91 (85%) Tagadharis and 73 (90%) Matwalis satisfied criteria for DSM-IV 
alcohol dependence. Contrary to our hypothesis, the prevalence of MD among Matwalis was 
higher (41%) compared with that among Tagadharis (32%) but the difference did not reach 
statistical significance (p=0.221). 
As shown in table 1, there were significant differences between depressed and non-depressed 
Matwalis in terms of sociodemographic variables. Among them, age group below 36 years, 
those not living in marital relation, and those who lacked a stable employment were more 
likely to be depressed. Experiencing alcohol induced blackouts was strongly related to having 
MD in Matwalis. Matwalis who were abstinent for longer duration and those admitting 
consumption of alcohol more frequent than 2-4 times per week were more likely to have MD. 
In case of Tagadharis, using alcohol as eye-opener, earlier onset of habitual drinking, having 
experienced more numerous withdrawal signs, and scoring higher in AUDIT were related to 
having depression. In fact, significantly more Matwalis than Tagadharis reported of having 
parental problem drinking, but having a problem drinker parent was strongly associated with 
MD only among the Tagadharis.  
Logistic regression analyses demonstrated the impact of the background variables on 
comorbidity. All models presented as blocks in table 2 were statistically significant (p<0.01). 
As presented, having a stable employment showed unique statistically significant 
contribution to the model with sociodemographic variables among Matwalis. Having 
experienced blackouts and longer abstinence period were retained as clinical predictors of 
MD among Matwalis. In case of Tagadharis, the only factor that withstood adjustment was 





The present study indicated that the rate of major depression among treatment seeking AUD 
patients in Nepal was around 40%, a figure lying between earlier observed extremes (37;38). 
Patients who experienced a major depression had shakier social truss and more often a severe 
alcohol-use disorder. To our knowledge, this is the first ever observation of differential 
occurrence of comorbidity in a society dichotomized by taboo on alcohol use. Contrary to 
what we had expected, belonging to a social class with a taboo on the use of alcohol was not 
related to higher rates of comorbid major depression in AUD patients. In fact, patients 
belonging to a lower social stratum with sanctioned drinking reported higher rates of 
depression. Predictors of major depression seemed to differ between the two social strata, 
with lack of stable employment and blackout experiences signifying MD in the non-tabooed 
class. Major depression among AUD patients in the tabooed stratum seemed to have 
transgenerational underpinnings. 
Rates of major depression among people with an AUD have been shown to vary between 
different settings, especially in treatment samples. Our findings were consistent with the 
literature from several other countries (8;15;24;45), but the rates were higher than reported 
from Iceland, and Korea (46;47). These differences may partly be elucidated in terms of the 
use of manifold measures of depression and varying psychometrics. For example, the 
reported rates of meta-analysis were derived from severe depression diagnosis as measured 
by Hamilton depression rating scale at various time points during treatment (24). Others used 
DSM-III or DSM-IV criteria, differing again in their settings and sampling frame. Stringent 
screening criteria for DSM-IV major depressive episodes applied in our study might have 
actually underestimated the „state‟ measures of depression. Although gender variation could 
not be assessed due to underrepresentation of females in the sample, vulnerability factors like 
younger age, lack of stable employment and not being in marital cohabitation were found 
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strongly associated with having a comorbid MD, particularly among the Matwali people. 
These findings support European multinational data (24) while contradicting earlier 
suggestions from Nepalese general population in that MD in our study was uniformly 
distributed across all income levels (33;48). The rates we are presenting may be influenced 
by treatment participation. Even in the US less than 6% AUD patients sought treatment (8). 
Tagadharis constituted majority (57%) of our sample despite the fact that this group 
represents less than a third of national population (30). Association of earlier onset of 
habitual drinking and a positive family history with MD among Nepalese AUD patients is 
consistent with available literature, but further investigation is necessary (17).  
Since Tagadhari people are subjected to social taboo on alcohol consumption, occurrence of 
comorbid MD could be better accounted for, as would be expected for drinking behaviour, by 
variables other than demographics, partially comparable to other „dry‟ cultures (49). This was 
supported by the higher prevalence of blackout experiences among Tagadharis. Interestingly, 
experiencing blackout was a consistent predictor of MD in the Matwali group only, pointing 
to the fact that even among a subset of Matwali people was drinking pattern an important 
correlate of comorbid MD.  The length of abstinence that indicated MD among Matwalis may 
be a function of longer involvement in treatment owing to severity represented by longer 
drinking career, higher average drinking units and numerous withdrawal features. Except for 
familial predisposition, Matwali group displayed characteristic features of depressed AUD 
patients of Nepal. There are enough overlaps of these traits across the groups suggesting 
departure from past taboos and transition towards modern drinking culture.  
Parental problem drinking which made the only consistent and meaningful correlate of MD in 
the Tagadhari group indicates towards the possibility of common familial factor for both the 
conditions. Our study supports previous findings that the adult children of problem drinkers 
report significantly higher symptoms of depressive affect and MD, and this seems applicable 
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among Nepalese problem drinkers (17;28;50). Interestingly, this phenomenon appeared 
unique among Tagadharis. The pathway by which paternal problem drinking moderates 
comorbid depression among AUD offspring is, however, not known. Exploration of risk 
trajectories from identification of common loci for susceptibility genes, adverse childhood 
experiences and externalizing disorders is necessary. 
A cautious interpretation of the results of this study is necessary as the sample is 
representative only of treatment seeking AUD patients. The hypothesis that belonging to 
higher class where social forces of taboo might increase occurrence of MD and interfere with 
help seeking behaviour could not be supported thus emphasizing that motivation in case of 
the Tagadharis and severity of illness in case of the Matwalis could possibly be stronger 
predictors of treatment seeking. The nature of the study does not permit inferences regarding 
the causality and the sequential ordering of the co-occurrence. However, we propose that 
primary AUDs and primary MD may be more common among Matwalis and Tagadharis, 
respectively. 
Treatment seeking AUD patients are important target for epidemiological studies of 
comorbidity since these individuals can provide insights into the unmet needs of the 
population. Clinical assessment of affective disorder in treatment seeking population, 
especially those with history of alcohol-use disorders, is mandatory. In local context, more 
tailored and broad based treatment facilities should be established in order to integrate 
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Table 1. Socio-demographic and clinical features of 12 month depressed and non-depressed Nepalese patients with an alcohol-use 
disorder by total, and subsample of alcohol related non-tabooed (Matwali) and tabooed (Tagadhari) group. 
 























Socio- demographics  
   
 
   
 
   
Age  below 36 years N (%) 60 (49.6) 44 (65.7) 0.046  22 (45.8) 24 (72.7) 0.023  38 (52.1) 20 (58.8) 0.539 
Male gender N (%) 108 (89.3) 60 (89.6) 1.000  41 (85.4) 26 (78.8) 0.552  67 (91.8) 34 (100) 0.174 
Urban origin N (%) 60 (50.0) 45 (67.2) 0.031  30 (63.8) 25 (75.8) 0.330  30 (41.1) 20 (58.8) 0.100 
Not cohabitation N (%) 38 (31.4) 35 (52.2) 0.008  15 (31.3) 19 (57.6) 0.023  23 (31.5) 16 (47.1) 0.135 
Non-nuclear family N (%) 48 (39.7) 35 (52.2) 0.125  17 (35.4) 17 (51.5) 0.174  31 (42.5) 18 (52.9) 0.405 
Education lower than 7 years N (%) 36 (29.8) 18 (26.9) 0.738  18 (37.5) 13 (39.4) 1.000  18 (24.7) 18 (24.7) 0.316 
Inadequate social support N (%) 33 (27.3) 21 (31.3) 0.615  12 (25.0) 11 (33.3) 0.459  21 (28.8) 21 (28.8) 1.000 
Unstable or no employment N (%) 42 (35.0) 35 (52.2) 0.030  13 (27.7) 21 (63.6) 0.003  29 (39.7) 29 (39.7) 1.000 
Low personal income (<60,000 
Nepalese Rupees/year) 
N (%) 36 (34.3) 19 (33.3) 1.000  19 (44.2) 14 (51.9) 0.625  17 (27.4) 17 (27.4) 0.306 
Clinical characteristics  
   
 
   
 
   
Institution (Rehabilitation centre) N (%) 102 (84.3) 59 (88.1) 0.524  38 (79.2) 28 (84.8) 0.574  64 (87.7) 31 (91.3) 0.749 
Beverage (Industrial) N (%) 55 (45.5) 36 (53.7) 0.290  18 (37.5) 14 (42.4) 0.817  37 (50.7) 22 (64.7) 0.213 
Drinking frequency (>2-4 days 
every month) 
N (%) 108 (89.3) 55 (82.0) 0.183  47 (97.9) 28 (84.8) 0.039  61 (83.6) 27 (79.4) 0.597 
Eye opener N (%) 85 (70.8) 56 (84.8) 0.034  36 (76.6) 25 (75.8) 1.000  49 (67.1) 31 (93.9) 0.003 
Blackouts N (%) 63 (53.4) 51 (78.5) 0.001  21 (45.7) 25 (78.1) 0.005  42 (58.3) 26 (78.8) 0.049 
Reduced important social or 
occupational activities 
N (%) 62 (51.2) 46 (68.7) 0.022  22 (45.8) 21 (63.6) 0.174  40 (54.8) 25 (73.5) 0.089 
Alcohol related police 
apprehensions 
N (%) 36 (29.8) 33 (49.3) 0.011  16 (33.3) 17 (51.5) 0.114  20 (27.4) 16 (47.1) 0.051 
Parental problem drinking N (%) 33 (27.3) 36 (53.7) 0.000  20 (41.7) 18 (54.5) 0.268  13 (17.8) 18 (52.9) 0.000 
Age at onset of habitual drinking  mean, SD 19.12 (6.33) 17.09 (6.33) 0.037  17.04 (5.87) 16.21 (6.09) 0.540  20.48 (6.29) 17.94 (6.52) 0.048 
Drinking career in years mean, SD 16.97 (10.09) 16.49 (9.43) 0.752  18.73 (10.04) 15.67 (9.52) 0.172  15.81 (10.01) 17.29 (9.41) 0.468 
Daily drinking units mean, SD 12.28 (5.43) 12.90(6.07) 0.527  12.9 (5.28) 12.74 (6.48) 0.921  11.97 (5.52) 13.03 (5.86) 0.404 
Current abstinence in days mean, SD 34.21 (30.71) 43.95 (34.31) 0.061  30.68 (28.99) 56.27 (33.88) 0.001  36.56 (31.78) 33.61 (31.61) 0.668 
Number of withdrawal signs mean, SD 5.37 (3.64) 6.88 (3.71) 0.009  5.78 (3.88) 6.81 (3.81) 0.248  5.09 (3.48) 6.94 (3.66) 0.015 
AUDIT average score mean, SD 2.73 (0.81) 2.90(0.94) 0.188  2.82 (0.78) 2.70 (1.04) 0.590  2.67 (0.83) 3.10 (0.81) 0.015 




Table 2. Odd ratio (OR) with 95 % confidence interval (CI) for reporting 12-month major depression by the total group of alcohol-use 
disorder patients within treatment and for the Matwali and Tagadhari community in Nepal according to socio-demographic and 
clinical characteristics 
 
Total  Matwali  Tagadhari 
 
OR (95% CI) aOR (95% CI)a  OR (95% CI) aOR  (95% CI)a  OR (95% CI) aOR  (95% CI)a 
Socio-demographic 
 
Block I  
 
Block III  
  
Age <36 Years 1.95 (1.05-3.61)* 1.38 (0.69-2.80)  3.15 (1.22-3.00)* 2.37 (0.80-7.03)  1.32 (0.58-3.00) 
 
Urban Origin 2.05 (1.09-3.81)* 1.89(0.99-3.56)  1.77 (0.66-4.78) 
 
 2.05 (0.90-4.68) 
 
Cohabitation (No) 2.39 (1.29-4.42)** 1.76 (0.86-3.61)  3.99 (1.19-7.50)* 1.34 (0.43-4.23)  1.93 (0.84-4.45) 
 




Block II  
 
Block IV  
 
Block V 
Eye-opener 2.31 (1.06-5.03)* 1.34 (0.52-3.45)  0.96 (0.37-2.71) 
 
 7.59 (1.68-34.40)** 3.89 (0.57-26.39) 
Blackout 3.18 (1.59-6.36)*** 2.68 (1.18-6.08)*  4.25 (1.53-11.78)** 4.07 (1.27-13.02)*  2.65 (1.10-6.91)* 1.52 (0.36-6.38) 
Drinking frequency (>2-4/month) 0.55 (0.24-1.29) 
 
 0.12 (0.01-1.07) 
 
 0.76 (0.27-2.20) 
 
Average drinks/day 1.02 (0.96-1.08) 
 
 1.00 (0.91-1.09) 
 
 1.03 (0.96-1.12) 
 
Abstinent period 1.01 (0.99-1.02) 
 
 1.03 (1.01-1.04)** 1.02(1.01-1.04)**  1.00 (0.99-1.01) 
 
Altered priorities 2.08(1.11-3.90)* 1.21 (0.54-2.7)  2.07 (0.83-5.13) 
 
 2.29 (0.94-5.58) 
 
Number of withdrawal signs 1.12 (1.03-1.22)** 1.06 (0.95-1.18)  1.07 (0.95-1.21) 
 
 1.17 (1.03-1.33)* 1.0(0.93-1.32) 
Parental problem drinking 3.10 (1.66-5.79)*** 3.58 (1.79-7.18)***  1.68 (0.69-4.11) 
 
 5.19 (2.11-12.80)*** 7.657(2.57-22.31)*** 
Drinking career 1.00 (0.97-1.03) 
 
 0.97 (0.92-1.02) 
 
 1.02 (0.98-1.06) 
 
Police apprehensions 2.29 (1.24-4.25)** 1.58 (0.78-3.20)  2.13 (0.86-5.27) 
 
 2.36 (1.01-5.50)* 1.91 (0.61-6.00) 
AUDIT average score 1.28 (0.89-1.84) 
 
 0.86 (0.52-1.44) 
 
 2.00 (1.13-3.54)* 1.19 (0.44-3.17) 
 
*P<0.05, **P<0.01, ***P<0.001; 
a
 aOR indicates adjusted odds ratios after adjusting for other variables within the block that were 
significantly related to being depressed 
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